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Abstract 
Kosinska, U., 2007. Salvage enzymes in nucleotide biosynthesis: Structural studies on three 
bacterial thymidine kinases and human uridine-cytidine kinase 1. Doctoral dissertation 
ISSN 1652-6880, ISBN 978-91-576-7348-0 
 
Balanced pools of deoxyribonucleoside triphosphates (dNTPs), the building blocks of 
DNA, and ribonucleoside triphosphates (NTPs), the precursors of RNA, are crucial for a 
controlled cell proliferation. The dNTPs and NTPs are synthesized de novo via energy-
consuming reactions involving low-weight molecules, and through a salvage pathway by 
recycling (deoxy)ribonucleosides originating from food and degraded DNA and RNA. The 
enzymes described in this thesis catalyze the first reaction in the salvage biosynthesis of 
dNTPs and NTPs. 
 
The crystal structures of three bacterial thymidine kinases (TKs) are described and the 
enzymes are investigated as potential targets for antibacterial therapies. TK is a 
deoxyribonucleoside kinase (dNK) with specificity for thymidine. In addition to the natural 
substrates, TK can also phosphorylate a number of nucleoside analogs used in antiviral and 
anticancer therapies. This thesis presents the structures of TKs from three pathogenic 
microorganisms:  Ureaplasma urealyticum (parvum),  Bacillus anthracis and Bacillus 
cereus, and compares them to the human thymidine kinase 1 (hTK1). The bacterial TKs and 
the hTK1 are structurally very similar and have a highly conserved active site architecture, 
which may complicate structure-based drug design. However, the different complex 
structures presented in this work provide information regarding the conformational changes 
of TK1-like enzymes during the time of reaction. 
 
The structure of human uridine-cytidine kinase 1 (UCK1) is also presented. Humans 
possess two uridine-cytidine kinases, UCK1 and UCK2. The expression pattern of these 
enzymes is tissue dependent, and despite high sequence as well as structural similarities 
they possess somewhat diverse substrate specificity. In addition to the natural substrates, 
uridine and cytidine, UCKs are able to phosphorylate a number of nucleoside analogs. The 
monomeric structure of UCK comprises four domains: a CORE domain, an NMP-binding 
domain, a LID domain and a β-hairpin domain, which upon substrate binding undergo 
dramatic conformational changes. In the structure described in this thesis the enzyme has 
been trapped in an intermediate conformation between a fully opened and fully closed form, 
which may represent a sequential mode of substrate binding. 
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Foreword 
Proteins play a central role in many biological processes and deserve their name, 
which comes from the Greek prota or proteios meaning of primary importance or 
first place. Functions such as structural support, storage, transport of chemical 
compounds, regulation of metabolic processes, signaling from one cell to another, 
mobility and defense against foreign substances, are all carried out by proteins. 
Moreover, proteins catalyze most of the chemical reactions that take place in cells. 
Such proteins are termed enzymes. 
 
The primary sequence, which subsequently determines the three dimensional 
structure of the protein, is determined by the genetic code in the form of DNA. 
Furthermore, the function of a protein is strongly dependent on its structure. Thus 
to establish a complete picture of biological processes we need to combine 
molecular biology with biochemistry and structural biology. Three methods are 
mainly used for protein structure determinations; electron microscopy, nuclear 
magnetic resonance (NMR), and X-ray crystallography. Electron microscopy can 
be applied in studies of large complexes of biological macromolecules, but the 
resolution limit is still too low for detailed structural studies. The limiting factor of 
NMR is the size of the biomolecule of interest, while the major obstacle of 
crystallography is obtaining well-diffracting crystals. Since no size limit exists in 
crystallography, this method has an application for structure determination of a 
variety of large assemblies of biological macromolecules. An example of such an 
assembly that recently regained large attention is the protein-DNA-RNA complex 
of the RNA polymerase for which Roger D. Kornberg was awarded the Nobel 
Prize in Chemistry in 2006. The first applications of X-ray crystallography on 
biological macromolecules reach 50 years back in time. At that time John C. 
Kendrew and Max F. Perutz were the foremost leading explorers of protein 
crystallography. In 1962 they were awarded the Nobel Prize for their 
determination of the myoglobin and hemoglobin structures. Yet another highly 
dedicated pioneer who has left deep footprints on protein crystallography is 
Dorothy C. Hodgkin. Her work resulted in the structure determination of insulin, 
but also the biologically significant substances like penicillin and vitamin B12, for 
which she was awarded the Nobel Prize in 1964. 
 
Today there are more than 35 000 structures solved by X-ray crystallography 
deposited in the Protein Data Bank, reflecting the immense advance of 
crystallography. In this thesis, the structure determination and biological relevance 
of six out of the 35 000 structures are described. The work presented here focuses 
on structural studies using X-ray crystallography on enzymes involved in the 
synthesis of deoxyribonucleoside triphosphates (dNTPs), the precursors of DNA, 
and nucleoside triphosphates (NTPs), the precursors of RNA. In particular three 
bacterial thymidine kinases originating from Ureaplasma urealyticum,  Bacillus 
cereus and Bacillus anthracis were investigated. By combining molecular biology 
with structural studies the aim was to investigate these enzymes in the light of 
future design of anti bacterial agents. Additionally, human uridine-cytidine kinase   10
1 was investigated in collaboration with Structural Genomics Consortium at 
Karolinska Institutet in Stockholm. 1. Synthesis of (deoxy)ribonucleoside 
triphosphates 
DNA replication and repair strongly depends on a balanced pool of the four 
deoxyribonucleoside triphosphates (dNTPs). The dNTP pools fluctuate during the 
cell cycle, increase for the period of DNA synthesis (the S-phase), and reach their 
lowest concentrations in the post-mitotic G0 phase. A general estimate is that 
pyrimidine dNTP pools are often larger than purine pools (Traut, 1994). The 
dNTP pools are in a way self regulated such that dNTPs control the activities of 
dNTP synthesizing enzymes via routes of feedback inhibition or allosteric 
regulation. Additionally, the dNTP pools may be kept balanced by regulating the 
amounts of enzymes responsible for their synthesis through cell cycle dependent 
expression and degradation. 
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Fig. 1. Overview of nucleotide metabolism. The salvage pathway recycles deoxyribonucleo-
sides (dNs) and ribonucleosides (Ns) from nutrients, and degraded DNA and RNA, whereas 
low-molecular weight compounds make the starting materials in the de novo synthesis.
NMPK
 
 
Most organisms have two pathways for dNTP synthesis, de novo and salvage, 
but some, for example Ureaplasma urealyticum, have to solely rely on salvaging 
enzymes to maintain balanced dNTP pools. The de novo synthesis uses low-
molecular-weight precursors to build up nucleotides whereas the salvage pathway 
recycles deoxyribonucleosides (dNs) from degraded DNA. Figure 1 gives a 
schematic representation of dNTP synthesis and shows how the two pathways 
meet at the junction when ribonucleoside diphosphates (NDPs) are reduced to 
deoxyribonucleoside diphosphates (dNDPs) by ribonucleotide reductase (RNR). 
Before NDPs reach RNR for the irreversible reduction, they are formed from 
small molecules such as glutamine, asparagine, aspartate, glycine, tetrahydrofolate 
derivatives, phosphoribosylpyrophosphate (PRPP), ammonia and CO2. Purine 
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nucleotides (adenosine and guanosine) are synthesized at the nucleotide level such 
that the purine ring is assembled on the ribose, while pyrimidine nucleotide 
(uridine and cytidine) synthesis takes place on the free base level. The final 
products of the de novo synthesis are nucleoside monophosphates (NMPs). As for 
dNs, there is also a salvage route for the synthesis of NMPs, in which nucleosides 
from food and degraded RNA are phosphorylated to the corresponding nucleoside 
monophosphates (NMPs). 
 
1.1 Enzymes in the de novo pathway 
1.1.1 Ribonucleotide reductase (RNR) 
Extensive studies of the mechanism, allosteric regulation, physiology and 
evolution of RNR have been performed and several reviews are available with the 
latest by Nordlund and Reichard (Nordlund & Reichard, 2006). RNR plays an 
important role in converting RNA precursors into DNA precursors by catalyzing a 
radical dependent reduction of the 2’-hydroxyl of ribonucleoside diphosphates. On 
the basis of their mode to generate the radical, the RNRs are divided into three 
classes. Class I RNRs contain a dinuclear iron center which generates and 
stabilizes a tyrosyl radical, class II enzymes use adenosylcobalamin to produce the 
radical, while class III enzymes harbor a [4Fe-4S] center, which together with S-
adenosyl methionine and reduced flavodoxin generates a glycyl radical. All three 
classes can be found in microorganisms, where class III is restricted to anaerobic 
microorganism. Eukaryotes possess only class I RNRs. 
 
Human RNR, a class I RNR, is a tetramer composed of two dimers R1 and R2. 
The R2 dimer is the smaller of the two dimers which generates and stores the 
radical. Upon substrate binding to the reaction site situated in the R1 dimer, the 
radical is transferred from R2 to a conserved cysteine residue in the reaction site in 
R1. The radical abstracts a hydrogen atom from the 3’-carbon of the ribose and 
produces a substrate radical. Electron transfer then generates a 2’-
deoxynucleotide. Since RNR reduces all four ribonucleotides (ADP, GDP, CDP 
and UDP) a rigorous regulation mechanism is required to control the enzyme in 
order to prevent dNTP pool imbalance. Thus, in addition to the reaction site, the 
large subunit has an overall activation site and a specificity site. The overall 
activation site works like a general on/off switch such that an ATP molecule 
bound to that site activates the enzyme while a dATP molecule turns it off. The 
specificity site determines which substrates will be processed by RNR. The type of 
ribonucleotide to be reduced depends on whether ATP, dATP, dTTP or dGTP is 
bound at the specificity site. Besides the allosteric regulation of RNR, the enzyme 
activity is also regulated by cell cycle dependent expression and degradation of the 
small subunit R2 (Chabes & Thelander, 2000; Chabes et al., 2003). In resting cells 
a p53-induced R2, p53R2, substitutes for the normal R2 and forms an active 
complex with R1 to supply the cell with dNTPs required for DNA-damage repair 
(Guittet et al., 2001). 
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1.1.2 De novo synthesis of dTTP involves dCMP deaminase, thymidylate 
synthase and dUTPase 
The synthesis of three (dATP, dGTP and dCTP) of the four DNA precursors is 
rather straight forward involving reduction of the ribonucleoside diphosphate by 
RNR and subsequent phosphorylation to the final deoxyribonucleoside 
triphosphate. The de novo synthesis of dTTP, however, requires additional steps 
where deoxycytidine and deoxyuridine nucleotides are remodeled to form dTTP. 
This conversion involves thymidylate synthase (TS), dCMP deaminase and 
UTPase (Reichard, 1988). TS catalyzes the conversion of dUMP to dTMP, which 
requires oxidation of 5,10-methylenetetrahydrofolate to dihydrofolate, and thus TS 
is dependent on an active dihydrofolate reductase. dCMP deaminase is an 
allosterically regulated enzyme activated by dCTP and inhibited by dTTP. It is the 
major supplier of dUMP and controls the relative amounts of dCTP and dTTP. A 
further route to provide TS with dUMP is provided by the reaction of dUTPase 
which cleaves dUTP to dUMP and a pyrophosphate. Moreover, the action of 
dUTPase effectively prevents dUTP accumulation which could lead to 
incorporation of uracil into DNA. In prokaryotic cells formation of dUMP takes 
place at the dCTP level where a dCTP deaminase produces dUTP which is further 
hydrolyzed to dUMP by dUTPase. 
 
1.2 Enzymes in the salvage pathway 
An alternative route to the de novo biosynthesis of (d)NTPs is the less energy 
demanding salvage pathway, in which (d)Ns are recycled to form their 
corresponding triphosphates. During the salvage pathway, extracellular (d)Ns 
originating from degraded cells or nutrients are transported into the cell via non-
specific nucleoside carrier proteins (Plagemann, Wohlhueter & Woffendin, 1988) 
and undergo three successive phosphorylation steps. In the first step 
deoxyribonucleoside kinases (dNKs) and ribonucleoside kinases (NKs) 
phosphorylate deoxyribonucleoside or ribonucleosides, respectively. Addition of 
negative charges in form of phosphates traps the phosphorylated nucleosides 
inside the cell, and therefore this step is often described as the rate limiting step. 
This provides substrates for subsequent phosphorylation steps catalyzed by 
nucleoside monophosphate kinases (NMPKs) followed by nucleoside diphosphate 
kinases (NDPKs). 
 
1.2.1 Deoxyribonucleoside kinases (dNKs) 
1.2.1.1 Human dNKs 
There are four dNKs in human cells: deoxyguanosine kinase (dGK), 
deoxycytidine kinase (dCK), thymidine kinase 1 (hTK1), and thymidine kinase 2 
(TK2) (Arnér & Eriksson, 1995; Eriksson et al., 2002). Two of these, dGK and 
TK2, are found in mitochondria, while the other two, dCK and hTK1, are 
cytosolic. These enzymes have partially overlapping substrate specificities, but a 
general division into purine and pyrimidine specific dNKs may be made. The two 
thymidine kinases, hTK1 and TK2 are strict pyrimidine kinases. The cytosolic   14
hTK1 only phosphorylates thymidine (dT) and deoxyuridine (dU), whereas the 
mitochondrial TK2 in addition to dT and dU can also phosphorylate deoxycytidine 
(dC). Deoxycytidine kinase may also be considered as a pyrimidine kinase 
although in addition to dC it is also active with deoxyadenosine (dA) and 
deoxyguanosine (dG). Finally, dGK is a purine kinase, but in addition to dA and 
dG can also phosphorylate dC. Moreover, a range of clinically important 
nucleoside analogs are phosphorylated, and thereby activated, by dNKs. 
 
Several nucleoside triphosphates can act as phosphate donors, with ATP being 
accepted by all dNKs. The activities of dNKs are controlled by feedback 
regulation. The triphosphate of the most preferred ribonucleoside acts as feedback 
inhibitor for the corresponding dNK, such that hTK1 and TK2 are inhibited by 
thymidine triphosphate (dTTP), dCK is inhibited by deoxycytidine triphosphate 
(dCTP) and dGK by deoxyguanosine triphosphate (dGTP) and deoxyadenosine 
triphosphate (dATP) (Arnér & Eriksson, 1995; Eriksson, et al., 2002; Ives, Morse 
& Potter, 1963). 
 
Based on their amino acid sequences dNKs form two distinct groups. One of the 
groups, the dNK-group, consists of sequences of human dCK, dGK, TK2 and their 
homologs. The second group only includes sequences similar to the cytosolic 
hTK1, thus the homologs of hTK1 described in this thesis will be referred to as the 
TK1-like enzymes. 
 
1.2.1.2 dNKs in other organisms 
The set of deoxyribonucleoside kinases as well as their preferences for phosphate 
acceptors differs among organisms. Drosophila melanogaster (Munch-Petersen, 
Piskur & Søndergaard, 1998), Bombyx mori  (Knecht et al., 2002a) and Anopheles 
gambiae (Knecht et al., 2003) possess one multisubstrate dNK, with high 
activities with all four dNs. On the other hand, in E. coli only TK activity has been 
detected and neither dCK, dGK nor deoxyadenosine kinases  (dAK) were found 
(Karlström, 1970). This seems to be a common feature for Gram-negative bacteria 
where only TK1-like sequences have been identified (Sandrini et al., 2006). Most 
Gram-positive bacteria, in addition to TK, possess one or two dNKs with 
specificities for the remaining deoxyribonucleosides. Extensive studies have been 
performed on dNKs from Bacillus subtilis and Lactobacillus acidophilus. In 
addition to TK, B. subtilis has two homodimeric enzymes, a strict dGK which only 
accepts dG as substrate and a deoxyadenosine/deoxycytidine kinase (dAK/dCK) 
which is equally active with dA and dC (Andersen & Neuhard, 2001; Møllgaard, 
1980). A rather interesting set of dNKs is present in L. acidophilus strain R26 
which seem to lack the RNR, and thus relies on the salvage pathway for dNTP 
synthesis (Ives & Ikeda, 1998). Besides a TK, L. acidophilus has two 
heterodimeric dNKs, dGK/dAK and dCK/dAK, that assure the salvage of the 
remaining three deoxyribonucleosides dA, dC and dG. Each subunit of the 
heterodimeric dNKs is specific for the individual substrate and is feedback 
inhibited by the triphosphate of its preferred deoxyribonucleoside. In 
mycoplasmas, offspring of Gram-positive bacteria, the set of dNKs have been 
reported to contain two enzymes, TK (Carnrot et al., 2003) with specificity for dT   15 
and dU, and dAK showing specificity for dA, dC and dG, with the highest 
catalytic rate for dA (Wang et al., 2001). 
 
Yet another dNK that should be mentioned is the thymidine kinase from Herpes 
Simplex Virus type 1 (HSV1-TK). HSV1-TK phosphorylates dT and dU, but is 
also active with purine deoxyribonucleosides. Interestingly, in contrast to the 
dNKs described above, HSV1-TK catalyzes two subsequent phosphorylation 
steps, such that a dN is phosphorylated to a deoxyribonucleoside monophosphate 
(dNMP) and the dNMP is phosphorylated to deoxyribonucleoside diphosphate 
(dTDP) (Chen et al., 1979; Chen, Walker & Prusoff, 1979). Moreover, HSV1-TK 
is a specific activator of nucleoside analogs, of which acyclovir and gancyclovir 
are commonly used as antiherpetic drugs (Gentry, 1992). HSV-1 TK is extensively 
studied for its potential to be applied in suicide gene therapy. 
 
1.2.1.3 dNK structures 
Intensive structural work has contributed to broadening our understanding of the 
enzymatic activities of some of the dNKs. For a very long time HSV1-TK was the 
only dNK with known structure (Brown et al., 1995; Champness et al., 1998; 
Wild et al., 1995; Wild et al., 1997). The first eukaryotic dNKs to be structurally 
determined were the multisubstrate D. melanogaster-dNK and human dGK, 
shortly after followed by human dCK (Johansson et al., 2001; Sabini et al., 2003). 
At the structural, but not at the sequence level, HSV1-TK is related to the enzymes 
of the dNK-group sharing the overall fold and quaternary structure. However, 
there are important differences in and around the active sites which explain the 
substrate specificities harbored by these enzymes (Eriksson, et al., 2002; Knecht et 
al., 2002b; Sabini, et al., 2003). The first TK1-like structures, the mycoplasmic 
TK (Uu-TK) and human TK1 which are described in Paper I, revealed that TK1-
like enzymes are structurally unrelated to other dNKs. In following sections the 
structures of Uu-TK, Bacillus anthracis and Bacillus cereus TKs (Ba-TK and Bc-
TK) are described in detail and compared to hTK1 as well as other TK1-like 
structures that are now available i.e. TK from Clostridium acetobutylicum (Ca-
TK) (Kuzin, 2004), Vaccinia virus TK (Vv-TK) (El Omari et al., 2006) and an 
additional, independently determined hTK1 (Birringer et al., 2005). 
 
1.2.2 Ribonucleoside kinases (NKs) 
Just as there is a salvage pathway for deoxyribonucleosides, there are several 
ribonucleoside kinases that phosphorylate ribonucleosides and thereby provide an 
alternative way to the de novo synthesis of nucleotides and deoxyribonucleotides. 
Only adenosine kinase (AK) and uridine-cytidine kinase (UCK) are known to exist 
in human cells (Ropp & Traut, 1996; Singh et al., 1996; Spychala et al., 1996; 
Van Rompay et al., 2001). Adenosine kinase is specific for adenosine, while 
uridine-cytidine kinase, whose structure is described in this thesis, phosphorylates 
uridine and cytidine. No human guanosine kinase has been identified, but a 
guanosine kinase or guanosine-inosine kinase is present in E. coli, Trichomonas 
vaginalis and in potato (Harlow, Nygaard & Hove-Jensen, 1995; Katahira & 
Ashihara, 2006; Miller & Miller, 1991).  
 
1.2.3 Reaction mechanism of dNKs and NKs 
The general mechanism for the phosphorylation reaction catalyzed by dNKs and 
NKs is presented in figure 2. A glutamic or aspartic acid acts as general base and 
initiates the reaction by deprotonation of the 5’-hydroxyl group of the ribose or 
deoxyribose acceptor. The 5’-oxygen is activated to perform a nucleophilic attack 
on the γ-phosphate of the ATP molecule so that the phosphate may be transferred 
to create a (d)NMP and ADP. The transition state may be balanced by a Mg-ion 
and arginines and lysines that commonly occur in the reaction sites of dNKs and 
NKs (Johansson, et al., 2001; Suzuki et al., 2004; Wild, et al., 1997). 
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Fig.2. General reaction mechanism for phosphate transfer as catalyzed by dNKs. A similar 
mechanism takes place in NKs with the exception that the phosphate acceptor is a 
ribonucleoside instead of a deoxyribonucleoside and the catalytic base is an aspartate. 
Because of its high abundance ATP is considered as the biological phosphate donor, but other 
nucleoside triphosphates are also accepted as phosphate donors. The figure was reproduced 
from Eriksson et al. 2002. 
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1.2.4 Nucleoside monophosphate kinases (NMPKs) 
The second phosphorylation step is catalyzed by nucleoside monophosphate 
kinases (NMPKs) present in most organisms. The requirement for the sugar 
moiety to be a deoxyribose is not as strict as in dNKs, and thus NMPKs are able to 
phosphorylate NMPs as well as dNMPs. On the other hand, as with dNKs, 
NMPKs are base specific. Consequently, human cells possess a thymidylate kinase 
(dTMPK), uridylate-cytidylate kinase (UMP/CMPK), several isoforms of 
adenylate kinase (AMPK) and several guanylate kinases (GMPKs) (Van Rompay, 
Johansson & Karlsson, 2000). As with hTK1, dTMPK has strict phosphate 
acceptor requirements and can only phosphorylate thymidine monophosphate 
(dTMP) and deoxyuridine monophosphate (dUMP). Moreover, dTMPK is cell 
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cycle regulated, as is the case with hTK1 (Huang et al., 1994). Low or absent 
dTMPK activity has been detected in nonproliferating tissues while fast replicating 
tumor cells show elevated activities. Structurally the NMPKs are classified in the 
nucleoside monophosphate kinase family (Yan & Tsai, 1999) with a general 
monomeric structure comprising CORE, LID and NMP-binding domains. These 
domains are also present in human uridine-cytidine kinase (UCK) thus they will be 
described in more detail in the section presenting the UCK1 structure. The 
bacterial set of NMPKs differs from the human NMPKs by containing two 
separate enzymes for phosphorylation of (d)UMP and (d)CMP. Especially, 
bacterial UMPKs are interesting deviants from the nucleoside monophosphate 
kinase family, acting as hexamers and being structurally more similar to the 
carbamate kinase-like superfamily (Briozzo et al., 2005). 
 
1.2.5 Nucleoside diphosphate kinases (NDPKs) 
The third and last phosphorylation of (deoxy)ribonucleoside diphosphates to 
corresponding triphosphates is catalyzed by nucleoside diphosphate kinases 
(NDPKs). NDPKs are non-specific and readily phosphorylate ribose and 
deoxyribose purine and pyrimidine nucleotides. In contrast to (d)NKs and NMPKs 
which form ternary complexes of enzyme, phosphate donor and phosphate 
acceptor where the phosphoryl group is transferred from the donor directly to the 
acceptor, NDPKs follow a ping-pong mechanism where the phosphoryl transfer 
occurs via a phosphoenzyme intermediate (Gilles et al., 1991). A crystal structure 
of NDPK in complex with transition state mimicking Al3 describes the catalytic 
mechanism of phosphate transfer from the ATP onto an active site histidine (Xu et 
al., 1997). As reviewed by Lacombe and colleagues, humans possess eight NDPK 
encoding genes with tissue dependent expression and subcellular localization of 
the protein. Besides the classical NDPK activity, NDPKs have been assigned 
functions associated with cell proliferation, development, differentiation and 
metastasis suppression (Kimura et al., 2000; Lacombe et al., 2000). Eukaryotic 
NDPKs are homohexamers while some bacterial NDPKs are homotetramers. 
Nevertheless they are built up from similar dimers. The subunits of NDPKs from 
different organisms have highly similar 3D structures with the core of the 
ferredoxin fold (Janin et al., 2000). However, formation of heterohexamers has 
been observed in human erythrocytes where the two NDPK polypeptides, A and 
B, form several isoenzymes by random association of these isoforms (Gilles, et al., 
1991). 
 
1.3 Medical applications of the salvage enzymes 
In addition to playing an important function in synthesis of DNA and RNA 
precursor, dNKs and NKs are also activators of a number of nucleoside analogs 
used in cancer therapies and treatment of viral infections. Nucleoside analogs are 
derivatives of natural ribonucleosides and deoxyribonucleosides with 
modifications on the base and sugar moieties. They are harmless prodrugs which 
have to be phosphorylated in order to display their pharmacological effect. The 
first phosphorylation step is catalyzed by nucleoside and deoxyribonucleoside   18
kinase. This is an important step in the activation process of the analogs since 
addition of the negative phosphate to the analogs traps them inside the cell. 
Phosphorylated nucleoside analogs act as antimetabolites and compete with 
natural nucleotides and deoxynucleotides. They interact with and inhibit a range of 
enzymes involved in the synthesis of nucleic acids. Ultimately, the nucleoside 
analog triphosphates are incorporated into the DNA and RNA where they cause 
strand termination, which leads to apoptosis. 
 
1.3.1 Nucleoside analogs 
The oldest known nucleoside analogs are the fluorinated uracil and deoxyuracil 
analogs, 5-flourouracil (FU) and 5-fluorodeoxyuridine (FdU) (Heidelberger et al., 
1957). These chemical compounds are efficient inhibitors of DNA synthesis and 
are still common anticancer drugs. Combination of biochemistry and structural 
biology helped to elucidate the mode of action for FU and FdU as tumor killers 
and it is now known that these compounds act, via their metabolite 5-
fluorodeoxyuridine monophosphate (FdUMP), as irreversible inhibitors of 
thymidylate synthase (Ichikawa, 2006). Better understanding of the basis of action 
of nucleoside analogs has led to a great expansion of cytotoxic nucleoside analogs. 
Some of the currently used analogs in chemotherapies against cancer are 
fludarabine, cladirabine and gemcitabine. All three are initially phosphorylated by 
dCK while the above described FdU is activated by hTK1 phosphorylation 
(Galmarini, Mackey & Dumontet, 2002).  
 
Nucleoside analogs are also used in chemotherapy of virus infections (De 
Clercq, 2001). Several anti-HIV drugs are nucleoside analogs which after 
activation by human dNKs, NMPKs and NDPKs inhibit the reverse transcriptase 
reaction of HIV which results in viral DNA chain termination. One of the first 
nucleoside analogs to be approved for treatment of HIV-infections was zidovudine 
(3´-azidothymidine or AZT). Acyclovir, also known as zovirax, and gancyclovir 
are two commonly used and highly specific anti-herpes virus agents. Their high 
specificity stems from the fact that the first phosphorylation step is catalyzed by 
the virus-encoded HSV-TK. The triphosphates of the antiherpetic analogs target 
the viral DNA polymerase and act as DNA chain terminators. 
 
1.3.2 Suicide gene therapy 
Suicide gene therapy or gene-directed enzyme prodrug therapy (GDEPT) aims to 
increase the selectivity of prodrugs for cancer cells (Niculescu-Duvaz & Springer, 
2005). This is achieved by transfecting cancer cells with a foreign gene, which 
encodes a highly specific drug-activating protein, followed by administration of 
the prodrug. Only the transfected cells will be able to activate the prodrug and will 
finally get killed by its cytotoxic effect. This method, which is mainly suitable for 
treatment of solid tumors, is currently under development, where delivery of the 
gene to the target cells and control of the gene expression are the largest obstacles 
to be overcome. A number of enzyme/prodrug combinations have been explored, 
and the most studied system is the HSV-TK/gancyclovir combination where the 
gene is delivered in a replication deficient adenovirus.   19 
2. Bacteria of interest 
The enzymes whose structures are presented in this thesis originate from three 
microorganisms;  Ureaplasma urealyticum and two related bacillus species 
Bacillus anthracis and Bacillus cereus. These pathogenic organisms are described 
bellow. 
 
2.1 Ureaplasma urealyticum 
Ureaplasma urealyticum is a member of the class Mollicutes, commonly referred 
to as mycoplasmas. Members of this class evolved from Gram-positive bacteria, 
but lack a cell wall. They are the smallest-known free-living organisms. The 
capability of autonomous growth, simple cell structure and small genome make 
mycoplasmas an interesting tool for exploration of the minimal gene set required 
to sustain bacterial life. A characteristic of ureaplasmas, which divides them from 
other Mollicutes, is their ability to hydrolyze urea to ammonia and CO2. This 
reaction is catalyzed by urease and contributes to 95% of the ATP production, 
which is driven by the electrochemical gradient produced by the ammonium ions 
(Smith et al., 1993). 
 
U. urealyticum is an opportunistic pathogen commonly found in the urogenital 
tract of humans. It is described as causing urethritis, premature spontaneous 
delivery, meningitis and pneumonia in neonates (Waites, Katz & Schelonka, 
2005). U. urealyticum can be transmitted from the mother to the developing fetus 
in the uterus or to the neonate at delivery. The infections are especially severe for 
neonates and the treatment options available at present have a series of problems. 
The first major dilemma results from the risks of medical therapy applied to 
neonates because of potential drug toxicities. Furthermore, the therapy requires 
frequent isolation of the microorganism from the mucosal surfaces, which is 
difficult to do without causing pain to the newborn. The second problem linked 
with therapeutic treatment of U. urealyticum infections is antibiotic resistance. 
Because of the absence of a cell wall in mycoplasmas and their simple 
biosynthetic mechanism the range of potential antibiotics against U. urealyticum is 
very limited. β-lactam drugs that inhibit cell wall synthesis and are thereby 
frequently used against Gram-positive bacteria have, in the case of U. urealyticum, 
no effect. Chloramphenicol, which inhibits the elongation step in protein 
synthesis, is not recommended for use in medical treatment of neonates because of 
bone marrow toxicity. For the same reason, and additionally because of the 
frequent development of resistance, tetracycline is excluded as potential drug 
candidate. Additional difficulties to finding potent treatment, for mycoplasma 
infections in pregnant women and neonates are due to limited clinical studies of 
the efficacy of antibiotics. Nevertheless, macrolides, for instance erythromycin, 
are currently suggested to be the best choice of antibiotics (Waites, Katz & 
Schelonka, 2005). 
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The genome of U. urealyticum (serovar 3), the most common serovar in 
humans, has been fully sequenced by Glass et al. (Glass et al., 2000). U. 
urealyticum has a small genome comprising ~750 kb. Biological roles have been 
assigned to 53% of the 613 predicted protein-coding genes. Interestingly, no genes 
encoding for the de novo biosynthesis of purines and pyrimidines, and no gene for 
RNR have been identified in the U. urealyticum genome. This brings about the 
necessity to import nucleosides and to rely of the salvage pathway to keep up a 
stable dNTP pool for the DNA synthesis. Surprisingly, no transporters for bases or 
nucleotides have been identified, but these may still be found among the 
hypothetical U. urealyticum proteins that have 5 or more predicted transmembrane 
regions. In addition, there are genes missing in order to fulfill the salvage pathway 
of dNTPs i.e. no nucleoside diphosphate kinase or thymidylate synthase has been 
identified. However, glycolytic kinases such as 6-phosphofructokinase, 
phosphoglycerate kinase and pyruvate kinase have been suggested to be possible 
replacements for the missing nucleoside diphosphate kinases in mycoplasmas 
(Pollack et al., 2002). 
 
Two years after the genomic characterization, it was agreed that U. urealyticum 
should be divided into two species: U. urealyticum and U. parvum (Robertson et 
al., 2002). As a consequence of the reclassification U. urealyticum (serovar 3) was 
renamed to U. parvum. For consistency with early literature we have kept the old 
name, thus whenever in this thesis or in the papers attached to it U. urealyticum is 
mentioned it refers to U. parvum according to the new classification. 
 
2.2 Bacillus anthracis and Bacillus cereus 
Bacillus anthracis,  Bacillus cereus and Bacillus thuringiensis belong to the 
Bacillus cereus group of organisms commonly found in soil and the gut of soil-
dwelling invertebrates (Jensen et al., 2003). These species are genetically highly 
similar and their functional differences are mainly assigned to the genes carried on 
plasmids (Rasko et al., 2005). For instance B. thuringiensis possesses plasmids 
carrying genes coding for insecticidal toxins often produced as intracellular 
protein crystals. Loss of these plasmids would make B. thuringiensis 
indistinguishable from B. cereus. Similarly, the virulence of B. anthracis is due to 
the genes present on two plasmids pX01 and pX02 (Okinaka et al., 1999) which 
are absent in B. cereus or non-pathogenic B. anthracis strains. The plasmid pX01 
harbors genes coding for three toxic factors while pX02 encodes a poly-D-
glutamic acid capsule protecting the bacterium from phagocytosis (Jensen, et al., 
2003). As a means of survival through environmental stress the members of the B. 
cereus group form endospores which after up-take by the host germinate into 
vegetative, virulent bacteria, eventually killing the host. In particular spores from 
B. anthracis possess properties that make them attractive biological weapons i.e. 
they are resistant to heat, ultraviolet and ionizing radiation, high pressure and 
chemical agents, and in addition they are easy to produce in large quantities. 
 
B. anthracis is the etiological agent of anthrax, a disease that is primarily found 
among herbivores. The infection is communicated to man via contact with infected   21 
animals causing cutaneous anthrax, or from eating inappropriately prepared meat 
from anthrax-infected animals resulting in gastrointestinal anthrax. The latter is 
very rare and occurs mainly in Africa and in parts of Asia but it is considered to be 
one of the most severe forms of the disease with fatal prognosis. There is yet a 
third type of the disease, the pulmonary or inhalation anthrax. As with the 
intestinal anthrax, this form has very high mortality rate (>80%) and is difficult to 
treat because the infection may stay unrecognized until it is too late for treatment 
(Baillie & Read, 2001). 
 
Penicillin and doxycycline are currently used for the treatment of anthrax, but 
also chloramphenicol, erythromycin, tetracycline and ciprofloxacin can be used 
(Dixon et al., 1999). Doxycylcline and ciprofloxacin are also used in prophylactic 
treatment of patients with suspected exposure to anthrax spores, while persons at 
risk for exposure to anthrax spores are vaccinated. Patients suffering from 
cutaneous anthrax may require intravenous therapies. However, these therapies 
mainly focus on elimination of the bacteria and need to be combined with 
antitoxin therapies. 
 
B. cereus is often associated with food poisoning. Two types of food poisonings 
are caused by B. cereus. One is characterized by diarrhea and abdominal pain and 
the other is associated with nausea and vomiting. The incubation time is 8-16 h 
before the symptoms break out and usually last for 12-24 h. B. cereus infections 
are rarely reported or diagnosed, and thus it is difficult to estimate the extent of the 
bacteria. The most common food product that is contaminated by B. cereus and its 
heat-resistant spores is rice, but also other dried products such as spaghetti, dried 
milk and spices may be infected. In addition to food poisoning B. cereus causes a 
number of non-gastrointestinal infections. These are usually associated with 
patients with impaired immune defense, neonates, drug addicts or patients with 
surgical wounds or catheters (Kotiranta, Lounatmaa & Haapasalo, 2000). 
 
There is a variety of B. cereus virulent factors that cause food poisoning or play 
a role in non-gastrointestinal infections (Kotiranta, Lounatmaa & Haapasalo, 
2000). Both multi-component as well as single protein enterotoxins with 
hemolytic, cytotoxic, dermonecrotic, vascular permeability and fluid accumulation 
effects have been found in food poisoning associated strains, whereas strains 
causing non-gastrointestinal infections have been reported to express collagenase 
and proteases e.g. with an ability to hydrolyze hemoglobin. Furthermore different 
forms of β-lactamase have been detected in different strains of B. cereus 
explaining its residence to β-lactam antibiotics.    22
3. Thymidine kinase 
3.1 Human TK1 
The monomer of human TK1 (hTK1) comprises 234 amino acids and has a 
molecular weight of 25.5 kDa. Discrepant data regarding the native weight of the 
hTK1 is presented in the literature with some reports stating hTK1 to be a dimer 
whereas others provide evidence for a tetrameric form of the enzyme (Berenstein 
et al., 2000; Birringer et al., 2006; Munch-Petersen et al., 1991; Munch-Petersen, 
Tyrsted & Cloos, 1993; Sherley & Kelly, 1988a). This issue will be further 
discussed in the forthcoming sections. In contrast to other human dNKs, hTK1 is 
cell cycle regulated. The TK1 activity increases during the G1/S phase of the cell 
cycle when DNA is replicated, but strongly decreases during late mitosis when 
cell division takes place (Bello, 1974). The molecular mechanism for the cell cycle 
dependent activity of hTK1 was ascribed to posttranslational regulation, but is not 
dependent on the hTK1 mRNA levels as was previously suggested (Coppock & 
Pardee, 1987; Sherley & Kelly, 1988b). Moreover, it was demonstrated that the 
fluctuation in TK1 activity corresponds to changes in the levels of hTK1 protein 
rather than being due to protein inhibition, and a signal for mitotic degradation 
was localized to a region between 10 and 40 amino acids from the C terminus of 
the hTK1 (Kauffman & Kelly, 1991; Sherley & Kelly, 1988b). Kelly and co-
workers correctly hypothesized that the degradation of human TK1 could be 
mediated by a highly specific protease that was active only during the early G1 
phase of the cell cycle. Recently a detailed study has shown that the rapid 
degradation of hTK1 during the end of mitosis is dependent on anaphase-
promoting complex/cylosome (APC/C) mediated ubiquitinylation, activated by 
Cdh1 (Ke & Chang, 2004). The degradation of hTK1 is initiated through binding 
of the APC/C-Cdh1 complex to a KEN box motif at the C terminus of hTK1. 
Similar KEN box motives are found in other mammalian TK1-like sequences, 
which consequently also exhibit cell cycle dependent TK1 activities, but are 
absent in most bacterial and viral TK1-like sequences where the C termini are 
usually shorter. 
 
As already mentioned, hTK1 phosphorylates dT and dU, but also some 
nucleoside analogs: FdU, 3’-fluorodeoxythymidine (FLT) and AZT (Eriksson et 
al., 1991; Munch-Petersen, et al., 1991). A further medical application of hTK1 is 
as a biomarker for cancer diagnosis and post-operative follow-up studies. Elevated 
hTK1 activity and concentration have been observed in blood serum of patients 
suffering from various solid cancers as well as leukemia and lymphoma (He et al., 
2005). The concentration of serum hTK1 has been shown to be a particularly 
sensitive marker for detection and post-surgical monitoring of breast, gastric, non-
small-cell lung and bladder cancer (Gronowitz et al., 1984; He et al., 2000; Li et 
al., 2005; Zhang et al., 2006; Zou et al., 2002). 
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3.2 Bacterial TKs 
Most bacteria, but not all, posses TK1-like enzymes (Saito & Tomioka, 1984; 
Saito, Tomioka & Ohkido, 1985; Sandrini, et al., 2006). The first bacterial TK to 
be biochemically characterized was from Escherichia coli where thymidine kinase 
is the only deoxyribonucleoside kinase present (Karlström, 1970). Recently TKs 
from  Ureaplasma urealyticum ( Uu-TK) and Bacillus anthracis ( Ba-TK) were 
cloned, purified and characterized (Carnrot, et al., 2003; Carnrot et al., 2006). Uu-
TK and Ba-TK consist of 223 and 195 amino acids respectively, and share 44% 
sequence identity. Both proteins share some enzymatic properties with human 
TK1 e.g. they are strictly pyrimidine specific and only phosphorylate dT and dU 
of the natural substrates and are feedback inhibited by dTTP. Compared with 
hTK1, Uu-TK and Ba-TK are less fastidious in their choice of phosphate donor, 
and besides ATP also accept GTP and other (d)NTPs. 
 
In the following section the structural studies of three bacterial thymidine 
kinases,  Uu-TK,  Ba-TK and Bc-TK are described. These enzymes have been 
trapped in different structural arrangements that are interpreted as conformational 
stages during the reaction pathway. The initiative to this work was based on 
expectations that the structural knowledge of TK1-like enzymes would contribute 
to future structure based drug design. As already described, lack of a de novo 
pathway for dNTP synthesis in U. urealyticum triggered the idea to use the 
salvage pathway in order to disturb the dNTP pools and consequently the DNA 
synthesis in the bacteria. Therefore, the possibilities of using Uu-TK in future anti 
bacterial therapies are evaluated. Finally, the sequential and structural relationship 
with hTK1 as well as other TK1-like structures is summarized. 
 
3.3 Uu-TK in complex with dTTP (Paper I) 
When our group commenced work on structure determination of thymidine kinase 
no homologous structures were known. Concurrent crystallization trials of human 
thymidine kinase 1 (hTK1) and thymidine kinase from U. urealyticum (Uu-TK) 
were initiated. The hTK1 and Uu-TK share 29% sequence identity, thus there was 
a possibility that once the structure of one thymidine kinase was solved it could 
provide a model for molecular replacement structure determination of the other. 
Very often things sound easier than they turn out to be and the most interesting 
proteins are often recalcitrant to crystallization. After two years of persistent 
attempts to grow well-diffracting crystals, hTK1 and Uu-TK, both in complex 
with their feedback inhibitor dTTP, were solved independently. The structure of 
hTK1 was solved with single isomorphous replacement with anomalous scattering 
(SIRAS) using gold as anomalous scatter, while the Uu-TK structure was 
determined with single wavelength anomalous diffraction (SAD) on 
selenomethionine (Se-Met) substituted enzyme. 
 
   24
3.3.1 Crystallization and structure determination 
The  Uu-TK was studied in collaboration with the department of Molecular 
Biosciences at SLU, Uppsala. Expression, purification and biomolecular 
characterization were performed by C. Carnrot (Carnrot, et al., 2003). Uu-TK 
crystallized easily in different kinds of PEGs, with or without addition of salts at 
neutral pH. Since the protein often formed micro crystals or crystal clusters, the 
difficulty was to make the enzyme form single-growing, sufficiently big, 
diffracting crystals. The Uu-TK was prone to precipitate in solution and the ability 
to form crystals diminished with time of storage at -80°C. Things were further 
complicated by the fact that Se-Met substituted protein had to be crystallized fresh. 
Screening with Hampton Research Additive Screen indicated that dithiothreitol 
(DTT) increased the size of the crystals. Se-Met substituted Uu-TK crystallized 
under very similar conditions to the native protein. In order to increase the size of 
Se-Met crystals streak seeding (Bergfors, 2003; Ducruix & Giegé, 1992; Stura & 
Wilson, 1990) was carried out. A seeding stock, prepared from a crushed crystal, 
was used to streak seed a drop that had been left to equilibrate for 2h. This gave 
rather large crystals, but as before, no single crystals were obtained. Using a 
micro-spatula, it was possible to separate the largest crystals and the structure of 
Uu-TK could be determined. 
 
3.3.1.1 How selenium turned out to be zinc – SAD phasing of Uu-TK 
Two data sets, one native and one SAD, were collected of Uu-TK in complex with 
dTTP. The crystals of native and Se-substituted Uu-TK were isomorphous and 
belonged to the monoclinic space group P21 comprising four subunits in the 
asymmetric unit. 
 
A highly redundant SAD data set was collected at the wavelength corresponding 
to the absorption energy at K-edge for selenium (λ=0.979Å, 12.66 keV). The 
crystals diffracted to approximately 3 Å and the anomalous signal was detectable 
to 4 Å resolution. Using data to 4 Å SHELXD (Schneider & Sheldrick, 2002) 
localized 12 heavy atom positions in the asymmetric unit with a sharp drop in 
occupancy between position 12 and 13. These sites where further refined in 
AutoSHARP (Bricogne et al., 2003; de La Fortelle & Irwin, 1997). Initially, all 12 
sites were thought to correspond to the selenium atoms, three for each monomer. 
The sequence of Uu-TK contains three methionine residues including the very first 
N-terminal residue. In the beginning of tracing of the polypeptide chain two of the 
heavy atom sites were assigned to Met21 and Met82, but the position of the third 
did not fit with the sequence. The first residue that was ordered was Ile11, which 
consequently strongly indicated that the third heavy atom site could not 
correspond to Met1. As the modeling proceeded it became clear that the third site 
did not correspond to a selenomethionine, but rather to a zinc ion, which was 
coordinated by three cysteines and one histidine. The anomalous contribution of 
zinc was possible since the absorption K edge for zinc is at a lower energy (9.66 
keV, λ=1.284) than for selenium. The presence of zinc ion was later on verified by 
atomic absorbance spectroscopy.  
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3.3.2 The structure of Uu-TK-dTTP 
The monomer is arranged in two domains; an α/β domain and a lasso domain (Fig. 
3A). The α/β domain is the larger of the two domains comprising 150 residues of 
the N-terminal part of the enzyme. The α/β domain is build up from a central, six-
stranded, parallel β-sheet flanked by a long α-helix on one side, and three shorter 
α-helices on the other side. The turn between β1 and α1 harbors a conserved 
phosphate binding motif, GXXXXGKS/T. The region connecting β2 with β3 
forms a β-hairpin which is perpendicular to the β-sheet, and is situated on the same 
side as the long α-helix. However, in two subunits this region is disordered and 
could not be traced. 
 
From the last β-strand of the central sheet, the chain continues to the lasso 
domain. The last 70 C-terminal residues fold into two perpendicular β-ribbons. 
The second ribbon, the longer one, opens up to form a big loop whose shape 
resembles a lasso. As will be described in the following section this domain 
mediates substrate binding, and because of its shape and function it was given the 
name lasso domain. The lasso loop is stabilized by two conserved residues, an 
arginine and a tyrosine. In contrast to the other residues found in the lasso loop, 
the arginine and tyrosine are the only two whose side chains are pointing into the 
middle of the loop and not towards the surface. The positioning of the β-ribbons 
with respect to each other is supported by a zinc ion. The metal is tetrahedrally 
coordinated by two cysteine residues of the first β-ribbon and one cysteine and 
one histidine residue situated after the second β-ribbon. The very last 10-15 
residues form into a C-terminal α-helix, which as will be shown, participates in 
tetramerization of Uu-TK. 
 
3.3.2.1 Catching the base with the lasso – the active site 
The active site is situated at the carboxy end of the central β-sheet, in between the 
α/β domain and the lasso domain. The thymidine base of the feedback inhibitor is 
buried in a deep, hydrophobic pocket, covered by the lasso loop. All the 
interactions between the base and the enzyme are with main-chain atoms of 
residues in the lasso and α/β domains. The side chain of the tyrosine, which was 
mentioned earlier as a lasso stabilizing residue, stacks against the thymine. Also 
the sugar moiety interacts only with the main chain of the enzyme. The 3’-
hydroxyl group makes hydrogen bonds with a conserved glycine in the lasso 
domain. The phosphates are more exposed and interact with the residues from the 
P-loop, where the only specific interaction with the ligand is provided by the side 
chain of a lysine residue. The negative charges of the phosphates are balanced by 
arginines, and in two subunits a Mg-ion is present in close proximity to the 
phosphates.  
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Fig. 3. The structure of Uu-TK. A) The monomer of Uu-TK with the feedback inhibitor 
dTTP. The dTTP binds as a bisubstrate analog with the base and sugar moieties in the 
acceptor site and the phosphates partly occupying the donor site. Structural Zn-ion is 
colored in gray and Mg-ion is in red. B) The tetramer of Uu-TK. C) The subunit-subunit 
interaction formed by an antiparallel helix pair. The subunits mainly interact via H-bonds 
formed between side-chain and main-chain atoms. D) The subunit-subunit interaction 
formed between the neighboring β-sheets. In addition to the interaction formed between the 
β−strands, helix α5 makes hydrophobic interactions with helices α2 and  α3 of the adjacent 
subunit.
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  263.3.2.2 Quaternary structure 
The Uu-TK forms a tetramer with 222 fold non crystallographic symmetry (Fig. 
3B). Two subunit-subunit interactions exist in the tetramer. One is formed 
between the long α-helices (α1) between neighboring subunits such that the 
helices make an antiparallel helix pair (Fig. 3C). The interactions are mainly 
provided through hydrogen bonds between side-chain and main-chain atoms. The 
second interaction, also formed in an antiparallel manner, is between the β-strands 
β6 and the helices α4 (Fig. 3D). The edge of the adjacent β-sheets interact through 
conserved hydrophobic interactions, salt bridges formed between an aspartic acid 
and an arginine, and hydrogen bonds between the side-chain nitrogen from a 
lysine residue in the strand of one subunit to the backbone oxygen in the other 
subunit. Moreover, a chain of water-mediated hydrogen bonds holds the subunits 
together. This subunit-subunit interaction is further strengthened by hydrophobic 
interactions formed between the C-terminal helix α5, which is stretched out and 
interacts with helices α2 and α3 in the neighboring subunit. 
 
3.4 The substrate complex of Uu-TK (Paper II) 
3.4.1 Crystallization and structure determination 
After determining the 3D structure of thymidine kinase, the next goal was to study 
the enzyme as potential drug activator and to further investigate the mechanism of 
phosphate transfer catalyzed by this enzyme. Attempts were made to co-crystallize 
Uu-TK together with a number of different nucleoside analogs, bisubstrate analogs 
such as P
1-(5’-adenosyl)-P
4-(5’-(2’-deoxythymidyl))-tetraphosphate, (AP4dT) and 
P
1-(5’-adenosyl)-P
5-(5’-(2’-deoxythymidyl))-pentaphosphate (AP5dT), as well as 
combinations of ADP and ATP analog adenosine 5’-[β,γ-methyleno]-triphosphate 
(AppCp) with dT (Fig. 4). Only the AppCp-dT crystals diffracted suitably for 
structure determination. As in Uu-TK-dTTP crystals, there were four subunits in 
the asymmetric unit and the space group was P21 with comparable cell parameters. 
The structure of this new Uu-TK complex was solved by molecular replacement 
using the inhibited Uu-TK as search model. 
 
 
 
 
 
 
 
AB CD
Fig. 4.  Crystals of Uu-TK co-crystallized with different ligands. A) ADP + 5-FdU 
B) AP4dT C) AP5dT D) AppCp + dT  
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3.4.2 The structure of Uu-TK-dT 
Only the substrate was bound to the Uu-TK and no density for the ATP analog 
was detectable. The phosphate donor site is occupied by water molecules and in 
one subunit by a Tris molecule. The overall structure of Uu-TK in complex with 
its substrate, dT, is highly similar to the inhibited enzyme. The main difference is 
focused to the phosphate binding area, where the flexible β-hairpin is absent or 
adopts a highly different conformation than observed in the dTTP complex. The 
substrate binds in the same manner as the base and deoxyribose moiety of the 
feedback inhibitor, with the thymine in a hydrophobic pocket between the α/β 
domain and the lasso domain. As for the dTTP molecule, hydrogen bond donors 
and acceptors of the thymine interact with the main-chain atoms of the enzyme 
(Fig. 5). The methyl group points towards the Cβ of a serine residue and is 
surrounded by other hydrophobic residues. In contrast to the dTTP complex, the 
side chain of Glu97 is directed into the active site and is hydrogen-bonded to the 
5’-hydroxyl group of the substrate. This conformation is in agreement with the 
proposed mechanism for phosphate transfer, where the glutamic acid plays the role 
of a catalytic base, as described in the introduction. A similar conformational 
change of the catalytic base, where the phosphates of the feedback inhibitor repel 
the side chain of the negatively charged glutamic or aspartic acid, has been 
described for the D. melanogaster-dNK (Mikkelsen et al., 2003) and UCK2 
(Suzuki, et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.  Two views of the acceptor binding site of Uu-TK. 
A) Thymidine interacts only with main-chain atoms of the enzyme. The methyl group  is in 
a hydrophobic environment surrounded by Cβ of Ser163, Leu124 and Met21. The side chain 
of Glu97 is H-bonded with 5’-OH  of the dT and may play the role as catalytic base. B) The 
thymidine base is surrounded by hydrophobic residues from the α/β domain and lasso 
domain.  
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Based on this structure we can confirm that the dTTP acts as a bisubstrate 
inhibitor, where the base and sugar moieties of the inhibitor are bound in the 
phosphate acceptor site and the phosphates partly occupy the phosphate donor site. 
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3.4.3 Uu-TK as drug target 
Uu-TK was investigated as potential prodrug activator. Several nucleoside analogs 
were tested as substrates or inhibitors of Uu-TK and the results were compared 
with hTK1 and put in light of the substrate complex of Uu-TK.  
 
The analogs that were studied included modifications either of the base 
(positions 3 or 5) or of the sugar (positions 2’ or 3’) (Fig. 6). The highest activity 
was obtained with 5-halogenated analogs. Substitutions as big as a cyclopropyl 
group at this position were accepted. Larger groups such as 5-(2-bromovinyl)-dU 
caused a significant decrease of activity, probably due to steric hindrance with 
residues that line the narrow pocket perfectly suited for a methyl group of dT. 
Analogs with alkyl modification at N3 position all showed lower activity 
compared with dT. Normally N3 is hydrogen-bonded to the carbonyl oxygen of a 
backbone residue in the lasso loop, but this interaction is lost with alkyl 
substitution. This prevents proper binding of the lasso loop which might be 
important for effective phosphorylation.  
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Fig. 6. The activity of Uu-TK with various substrate analogs. The percentage values 
indicated correspond to the enzyme activity with 100 µM analog as compared to the activity 
with 100 µM dT.
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When it comes to modifications of the sugar moiety, it was shown that analogs 
with small, polar groups at the 3’-position were accepted as substrate with about 
50% of activity retained, whereas nonpolar substitutions resulted in loss of 
activity. Similarly as for the N3 substitution this is connected with the possibility 
of hydrogen bond formation between the backbone of the lasso loop and the 
substrate. The 2’-position turned out to be the least suited for modification. 
Analogs altered at this position demonstrated the lowest activities of all analogs 
tested. The binding site is rather crowed around the 2’-position so the great loss of 
activity with these analogs was expected. 
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Two nucleotide analogs, 3’-fluoro-dT (FLT) and 3’-fluoro-5-cyclopropyl-dU 
(FCPU), showed slightly higher relative activities with Uu-TK than with hTK1. 
However, subsequent kinetic experiments showed that hTK1 was more efficient 
with these analogs as substrates than Uu-TK.  
 
Moreover, some of the nucleotides were tested for their ability to act as 
inhibitors for thymidine phospharylation. The Uu-TK and hTK1 show diverse 
abilities to withstand inhibition. For instance 5-fluoro-2’-deoxyuridine (FdU) gave 
a 20 times higher IC50 value (the concentration needed to inhibit 50% of the 
enzyme activity) for Uu-TK compared with hTK1. On the other hand, 2’-fluoro-
arabinosyl-5-iodo-2’-deoxyuridnie (FIAU) and 3’-azido-methyl-2’-
deoxythymidine (AZMT) showed approximately 5 times lower IC50 values for Uu-
TK than for hTK1. 
 
To summarize, we have seen that analogs with modification at 5- and 3’-
position were readily phosphorylated by Uu-TK, but at the same time these 
analogs were also equally well accepted as substrates by hTK1. In order for a 
compound to be considered as a potential therapeutic agent it must show a 
significantly different enzymatic pattern with the target enzyme than with the 
corresponding enzyme of the host. These results show that we are far from finding 
a good antibiotic that either would act as an exclusive substrate for Uu-TK or 
would be a selective inhibitor against Uu-TK. 
 
3.5 Thymidine kinase from B. anthracis and B. cereus (Paper III) 
The project on bacillus TKs was carried out in collaboration with the group of 
Prof. J. Piskur currently at the department of Cell and Organism Biology at Lund 
University, Sweden (Bc-TK) and with the group of Prof. S. Eriksson at the 
department of Molecular Biosciences at SLU, Uppsala, Sweden (Ba-TK). These 
groups kindly provided us with the material for structural studies. 
 
Thymidine kinases from B. cereus and B. anthracis have 96% sequence identity. 
In addition to five C-terminal amino acids, the enzymes differ by three residues. 
These residues are situated far from the active site, they are not part of the 
tetramerization regions, and do not, in any other aspect, affect the structures of the 
enzymes. Hence, Bc-TK and Ba-TK may be considered as structurally identical. 
 
3.5.1 Crystallization and structure determination 
The Bc-TK crystallized in a variety of conditions, forming different crystal forms 
(Fig. 7), but it was only the bipyramidal crystals, grown in a high concentration of 
2-methyl-2,4-pentanediol (MPD), that diffracted. Similarly, the crystals of Ba-TK 
adopted a bipyramidal morphology and likewise Bc-TK grew in an organic 
precipitant, 1,2-propanediol. 
 Both the Ba-TK and the Bc-TK crystals belonged to the tetragonal space group 
I4122 with the asymmetric unit comprising one subunit. However, the crystal 
packing differs significantly for the Ba-TK and Bc-TK, which is mirrored in the 
difference in the cell parameters. The structure of Ba-TK was solved by molecular 
replacement using a polyalanine model of Uu-TK. Subsequently, the structure of 
Bc-TK was solved using the structure of Ba-TK. 
 
 
 
 
 
 
 
Fig. 7. Different crystal forms of Bc-TK. 
The data were collected from the bipyrami-
dal crystals, which resemble the Ba-TK 
crystals.   
 
 
3.5.2 The structure of Ba-TK 
The monomer of Ba-TK is highly similar to the Uu-TK monomer (Fig. 3). The 
structures can be superimposed with root-mean-square distance (r.m.s.d.) of 0.8 Å 
for 165 Cα atoms. The substrate, dT, is bound in the same way as described for 
Uu-TK, with the base in a hydrophobic environment created by residues from the 
α/β and the lasso domains. The side chain of the catalytic base, Glu89, takes the 
same conformation as the corresponding residue in the substrate complex of Uu-
TK, towards the active site, and forms a hydrogen bond with the 5’ hydroxyl 
group of the deoxyribose. There was no electron density for the β-hairpin 
(residues 46-68) situated in the α/β domain and this is the only part of the structure 
missing in the model. A tetramer, equivalent to the Uu-TK tetramer, is formed by 
application of symmetry operators. 
 
3.5.3 The structure of Bc-TK 
The overall topology of Bc-TK is not surprisingly highly similar to Ba-TK and 
Uu-TK. However, a few interesting differences exist which need to be highlighted. 
The Bc-TK was co-crystallized with the feedback inhibitor, dTTP, hence, it was 
very intriguing to find the acceptor site empty and instead discover clear density 
for a nucleoside triphosphate at the phosphate donor site. Since a high 
concentration of ATP was used during one of the purification steps, the density 
was initially thought to represent an ATP molecule. However, the possibility that 
the density represented the dTTP molecule bound backwards compared to its 
binding as a feedback inhibitor was not ruled out, and both ligands were 
considered during the refinement process. Judging from the electron density 
corresponding to the base and sugar moieties, the ligand was interpreted as a dTTP 
molecule. According to the biochemical data available for Uu-TK (Carnrot, et al., 
2003) and hTK1 (Ives, Morse & Potter, 1963), dTTP is strictly an inhibitor and 
does not act as phosphate donor in TK1-like enzymes. Thus, it was surprising to 
find the dTTP mimicking a phosphate donor in the Bc-TK structure. However, 
later characterization of the Ba-TK showed that this enzyme may use dTTP as 
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phosphate donor, but to a lower degree than ATP (Carnrot, et al., 2006). Shortly, it 
became clear why dTTP was bound as a phosphate donor and not as a feedback 
inhibitor despite the fact that it has a much higher affinity for the acceptor site than 
for the donor site. During the final runs of refinement, electron density, too big to 
correspond to a water molecule, became visible in the acceptor site in the exact 
position for the base of a substrate or feedback inhibitor. The density was assigned 
to represent an MPD molecule, which was used as crystallizing agent. Finding 
MPD at or near the active sites is not unusual and has been reported for a number 
of structures. A review of MPD as crystallizing agent is available (Anand, Pal & 
Hilgenfeld, 2002). 
 
Although the acceptor site was occupied by an MPD molecule, the ligand did 
not provide sufficient hydrogen bonding partners to stabilize the lasso loop. 
Consequently, the lasso loop is in an open conformation. Similar flexibility in the 
lasso loop is present in the structure of thymidine kinase from C. acetobutylicum 
(Ca-TK) in complex with ADP (Kuzin, 2004), where parts of this region are 
missing in the model. In Bc-TK the open conformation of the lasso was stabilized 
by crystal contacts which enabled tracing the entire loop. 
 
Let us now move to the phosphate donor binding site, where the most interesting 
conformational differences are found. An occupied donor site influences the 
conformation of the tetramer. The tetramer of Bc-TK is not as compact as the 
tetramer of Ba-TK, or of any other TK1-like enzyme with an empty donor site. 
The distance between two subunits at the helical interaction is 3 Å wider in Bc-
TK, and this allows the base of the dTTP to stack between two phenylalanine 
residues, one from each subunit (Fig. 8). The separation of the subunits and the 
stacking interaction of the phosphate donor base between hydrophobic residues of 
neighboring helices are in agreement with the Ca-TK structure in complex with 
ADP. The opening of the tetramer, or formation of a less tight tetramer, is 
necessary to create space for the base of the nucleotide to stack between the 
adjacent helices. Moreover, the open tetramer prevents steric clashes that 
otherwise would occur between the P-β-hairpins of neighboring subunits, and 
between the residues situated on the tip of the P-β-hairpin and the neighboring α-
helix. Moreover, the phosphates of the donor provide stabilizing binding 
possibilities for the residues in the P-β-hairpin. Accordingly, the P-β-hairpin could 
be fully traced in the Bc-TK structure, and the tip of the hairpin hydrogen bonds 
with phosphates of the dTTP. 
 
 
 
 
 
 
 
 
 
 
  
 
12.5Å
Fig. 8. The distance between two subunits at the helical interaction is 3 Å wider when the 
phosphate donor is bound as in Bc-TK with dTTP (A), compared to when the donor site is 
unoccupied as in Ba-TK with dT (B). In Ba-TK with dT in the acceptor site the lasso loop is 
closed down over the active site, whereas in Bc-TK the loop has an open conformation. The 
distances in the figure are measured between Cα−atoms of residues 23 and 26 of the neigh-
boring helices.
A
9.6Å
B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6 Comparison of TK1-like enzymes 
3.6.1 Amino acid comparison 
Amino acid sequence alignment divides bacterial TKs in two groups: the TKs 
from Gram-negative bacteria and TKs from Gram-positive bacterial including 
mycoplasmas (Fig. 9). The sequence identity is 60-70% within each group but 
only around 20-30% between the groups. Some of the conserved motifs, both of 
enzymatic and structural importance, were identified first after the TK-structures 
were determined. Below, the TK sequences of Gram-positive and Gram-negative 
bacteria are compared and discussed. The analysis is based on 11 TK sequences 
from Gram-positive bacteria, 10 mycoplasmic TKs and 5 TKs from Gram-
negative bacteria. An alignment of selected sequences is provided in figure 9. A 
similar sequence relationship in TK1-like kinase of bacterial origin has been 
reported (Sandrini, et al., 2006). 
 
  The phosphate binding motif, P-loop (GXXXXGKS/T)(Saraste, Sibbald & 
Wittinghofer, 1990) is the only conserved region among all dNKs including 
enzymes of both the dNK-family and TK1-like enzymes. It is situated on the loop 
connecting the first β-strand, β1, with the first α-helix, α1. The residues of this 
region take part in positioning the phosphates of the phosphate donor and ligate 
the phosphates of the feedback inhibitor. The significance of the lysine has been 
ascertained by numerous mutation studies of a number of GTP/ATP binding 
proteins where the mutants demonstrated decreased enzymatic activity and 
reduced substrate affinity (Reinstein, Schlichting & Wittinghofer, 1990; Sigal et 
al., 1986; Tian et al., 1990). In Vv-TK, substitution of the conserved lysine by a 
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hydrophobic isoleucine decreased the ATP affinity and led to loss of enzymatic 
activity (Black & Hruby, 1990a). The first glycine in the P-loop is substituted with 
a serine in Gram-negative bacteria. A small, polar residue at this position should 
not cause any major steric hindrance for ATP binding and the hydroxyl group of 
the serine residue should be able to interact with the oxygen atoms of the 
phosphate groups. Changing any of the glycines to valine residues, however, was 
shown to significantly lower the enzyme activity, probably because the larger 
valine residues hinder the access of ATP to the binding site or cause 
conformational changes of the protein (Black & Hruby, 1990a; Liu & Summers, 
1988; Reinstein, Brune & Wittinghofer, 1988). 
 
The region of the P-β-hairpin contains five conserved residues (D51, R53, S60, 
R61 and G63 using the numbering of the Uu-TK sequence). In those TK structures 
where this region is visible, it can be observed that the aspartic acid (D51) 
hydrogen bonds with the 3’-hydroxyl group of the acceptor deoxyribose. The side 
chain of one of the arginines (R53) points toward the active site and it is likely that 
this residue will stabilize the transition state. The second arginine (R61) is in most 
Gram-positive bacteria substituted by a histidine. In the structure of Bc-TK this 
residue is positioned at the tip of the P-β-hairpin and together with the preceding 
serine hydrogen bond to the phosphate donor. 
 
Approximately 80 residues from the P-loop there is a conserved DEXQF motif 
is in all bacterial TKs. Generally there are four hydrophobic residues before the 
aspartic acid in Gram-positive bacteria but three in Gram-negative. It has been 
suggested that the corresponding aspartic acid residue in Vv-TK (D82) is involved 
in Mg-binding (Black & Hruby, 1992). The available TK1-like structures reveal 
that the corresponding aspartic acid indeed is oriented toward the metal, but the 
distance between the magnesium ion and the side chain is rather long to be 
considered as a metal-ligand bond. The glutamic acid which follows the 
asparagine has been suggested to act as the catalytic base which deprotonates the 
5’-hydroxyl group of the deoxyribose (Papers I & II), while the phenylalanine is 
one of the hydrophobic residues of the acceptor binding site. The glutamine has a 
structural role. 
 
Further conserved motifs among bacterial kinases are situated at the C-terminal 
part of the sequence. Black and Hruby made an early observation (Black & Hruby, 
1990a; Black & Hruby, 1992) that all the TK1-like sequences that were available 
at that time, contained a conserved cysteine residue (C170 in VvTK, C191 in Uu-
TK and C183 in Ba-TK/Bc-TK). Incorrectly, they speculated that this residue was 
involved in nucleophilic attack on ATP or in ligating the Mg ion. The structures of 
TK1-like enzymes have made us attentive to two Zn-binding motifs, CXXC and 
CXXC/H similar to those in other well known, zinc-containing proteins such as 
the tumor repressor p53 (Cho et al., 1994) or the glucocorticoid receptor (Härd et 
al., 1990), as well as the adenylate kinases of Gram-positive bacteria (Berry & 
Phillips, 1998; Gilles et al., 1994). In between the two zinc pairs there are two 
additional, structurally important and highly conserved residues - an arginine and 
a tyrosine. These are the residues holding up the lasso loop. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Sequence alignment of TK1-like sequences from mycoplasmas (U. urealyticum 
(Q9PPP5),  M. pneumoniae  (NP_109732.)), Gram-positive bacteria (B. anthracis (Q81JX0),        
B. cereus (DQ384595), C. acetobutylicum (NP_349490), C. perfringens (NP_563120), L. mono-
cytogenes (NP_466067)), Gram-negative bacteria (E. coli (NP_415754), Y. pestis (NP_405720)) 
and human (P04183). The secondary structure elements and the sequence numbering shown 
above the alignment correspond to Uu-TK. The P-loop, the Mg-binding and the Zn-binding 
motifs are boxed. Residues indicated with a star stack the base of the phosphate donor, a 
triangle indicates the conserved residues in the P-β-hairpin, while the squares indicate the 
Tyr-Arg couple, which stabillizes the lasso loop. The catalytic base is in bold. Residues that 
take part in the subunit-subunit interactions are shown against gray background. It is interest-
ing to notice that TKs from the Gram-positive   C. perfringens and L. monocytogenes align 
with TKs from Gram-negative bacteria. The alignment was made using ClustalW (Chenna et 
al., 2003), and Alscript (Barton 1993).
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So far we have not come across any major discrepancies between the Gram-
positive and Gram-negative TK sequences. However, the residues involved in the 
binding of the adenine moiety of the ATP differ. As is observed in the structures 
of Bc-TK (Paper III) and Ca-TK (Kuzin, 2004), the base of the phosphate donor is 
stacked between two hydrophobic residues, one from each adjacent subunit. At the 
equivalent positions in Gram-negative bacteria there is an asparagine and a 
glutamic acid. There is no structure of any TK from Gram-negative bacteria 
available, but it is clear that these organisms will bind the phosphate donor in a 
different way. 
 
Also residues involved in subunit–subunit interactions differ between Gram-
positive and Gram-negative bacteria, but these differences will most likely not 
affect the oligomeric form of the TKs. The β-sheet interaction involves the 
E/DXXhXK/E motif, situated on strand β6, and an arginine situated in the second 
Zn-binding pair, CRXC/H. The hydrophobic residue, Xh, is predominantly a 
valine in Gram-positive bacteria, whereas Gram-negative prefer a leucine or 
isoleucine at this position. The subunits interact through van der Waals 
interactions between the hydrophobic residues and by hydrogen bonds formed 
between the glutamic or aspartic acid and arginine, and between lysine or glutamic 
acid and main chain atoms. The subunit interaction formed between α-helices 
involves hydrogen interaction between side chains and the main-chain atoms. In 
Gram-positive bacteria there are two arginines that interact with the backbone of 
the neighboring α-helix. In Gram-negative bacteria, these arginines are substituted 
by glutamine and asparagine, thus the possibility to form similar subunit 
interactions as in Gram-positive bacteria is retained. 
 
Finally, the hydrophobic active site residues will be explored. In general all the 
phenylalanines that build up the active site are well conserved, but the 
hydrophobic residue situated on the lasso loop (I178 in Uu-TK ) is in Gram-
negative bacteria a polar glutamine. Furthermore, the position near the methyl 
group of the thymine differs among TKs. In Uu-TK there is a serine residue 
(S163) whereas other Gram-positive bacteria, as well as hTK1, have a threonine at 
this position. In Gram-negative bacteria, valine is the most frequent residue at this 
position. Interestingly, C. perfringens has an asparagine facing the methyl group 
of the thymidine. The effect of these alterations on the enzymatic activity has not 
yet been explored. 
 
3.6.2 Structural comparison 
3.6.2.1 Comparison of bacterial TKs with hTK1 
Despite moderate sequence identity between the bacterial TKs and hTK1, below 
30%, the 3D structures are highly similar, indicating a common ancestor. The 
subunits of hTK1 and Uu-TK may be superimposed with an r.m.s.d of 1.2 Å for 
147 Cα atoms. Like the bacterial TKs described in this thesis, the crystal structure 
of hTK1 is a tetramer with comparable subunit-subunit interactions as illustrated 
for the bacterial TKs (Paper I; Birringer, et al., 2005). Also the topology of the 
monomer is similar to the bacterial TKs (Fig. 3). The P-β-hairpin region is only 
visible in one monomer of the available hTK1s (Birringer, et al., 2005) and is very   37 
dissimilar from the β-hairpin observed in bacterial TKs. In hTK1 this region folds 
into two short α-helices that are involved in crystal packing, thus the unusual 
conformation might be a result of crystallization. The lasso loop, which has not 
been found in any other protein, is slightly shorter than in Uu-TK and other 
bacterial TKs. Since a C-terminally truncated hTK1 was used for structure 
determination, there is no structural data for the last 41 residues of the hTK1, 
which in hTK1 harbors the KEN sequence predicted to serve as ubiquination 
ligase signal involved in mitotic degradation of hTK1 (Ke & Chang, 2004). A 
model for this part of the enzyme is provided by the full-length Uu-TK structure. 
 
3.6.2.2 Bc-TK compared to Ca-TK 
The structures of Bc-TK with dTTP and Ca-TK in complex with ADP (but empty 
acceptor site) (Kuzin, 2004) are so far the only TK1-like structures with occupied 
phosphate donor sites. In agreement with what we have observed in the Bc-TK, 
the lasso loop of Ca-TK is in an open conformation and the tetramer shows a 
similar, loose conformation as in Bc-TK. The distance between the α-helices that 
make up the helical subunit interface is equivalent to the Bc-TK, but longer than in 
Uu-TK, Ba-TK and hTK1. 
 
3.6.2.3 Search for structural relatives to TK1-like enzyme family 
A DALI (Holm & Sander, 1993) search reveals that the α/β domain of TKs is 
structurally more related to enzymes from the RecA-F1ATPase family (Story, 
Weber & Steitz, 1992), in particular CobA (Bauer et al., 2001), rather than to 
other dNKs (Fig. 10A,B). The α/β domain of TK1-like enzymes differs from the 
α/β domain of dNKs in strand order, the number and size of α-helices and in the 
architecture of the active site. The lasso loop is substituted by a helical domain and 
an arginine rich LID domain, which cover the active site (Fig. 10C). Despite the 
structural differences pointing to a different evolutionary origin, TK1-like 
enzymes and dNKs catalyze the phosphorylation of deoxyribonucleosides in a 
similar way and all are feedback inhibited by the end products of the salvage 
pathway.  
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Fig. 10. Superposition of Uu-TK (in orange) 
on A) CobA, B) RecA and C) human dGK 
with dATP. The r.m.s.d. value for the 
superposition of the α/β domain of Uu-TK 
on CobA is 1.5 Å for 87 Cα atoms , on RecA 
is 1.5 Å for 88 Cα atoms, and on dGK is 1.8 
Å for 60 Cα atoms. In panels A and B the 
view is down on the carboxy end of the β−
sheet and only the α/β domain of the Uu-TK 
is shown. In panel B only the α/β domain of 
RecA is shown.
 
 
3.7 Concluding remarks 
3.7.1 Conformational changes through the reaction 
The different complex structures of thymidine kinases presented in this thesis 
allow us to speculate about the conformational changes that occur during the 
course of reaction. The monomer may be considered to consist of three domains: a 
rigid α/β domain and two flexible domains, the P-β-hairpin and the lasso. The 
flexible domains become stabilized upon ligand binding. When the enzyme is 
empty, awaiting the substrates to bind, both the lasso loop and the P-β-hairpin are 
unordered and the active site is accessible for the substrates (Fig 11A). As soon as 
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substrate, while the phosphate donor stabilizes the P-β-hairpin (Fig 11B). The 
flexible domains are also stabilized by the feedback inhibitor, such that the lasso is 
closed down over the active site (Fig 11C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AB C
Fig. 11. Different conformations of TK1-like enzymes. A) Awating the substrates - lack of 
stabilizing interactions from the ligands leaves the lasso loop open. The  P-β-hairpin could 
not be traced. B) Ready for the reaction to take place - both substrates, ATP and dT, are bound 
and stabilize the lasso and the  P-β-hairpin in their closed conformations.  C) Inhibited - the 
feedback inhibitor occupies both the phosphate acceptor and phosphate donor sites. The 
lasso is closed  and the P-β-hairpin has a slightly different conformation than in the active 
form. The model in panel A is a combination of the α/β domain from Ba-TK and the open 
lasso domain of Bc-TK. In panel B the α/β domain from Bc-TK  was combinde with the lasso 
domain of Ba-TK. ATP was modeled based on the dTTP binding in Bc-TK. Panel C shows 
Uu-TK with dTTP.  
 
3.7.2 Quaternary structure 
The quaternary structure of TK1-like enzymes has for a long time been a matter of 
debate. In the beginning of the 1980s, Hruby and Ball suggested that the vaccinia 
virus TK acts as a tetramer (Hruby & Ball, 1982), which some years later was 
verified by a number of biomolecular techniques (Black & Hruby, 1990b). 
However, contradictory results exist regarding the quaternary structure of the 
hTK1. It was shown that hTK1 forms dimers in the absence and tetramers in the 
presence of ATP (Munch-Petersen, Tyrsted & Cloos, 1993). Both the dimeric and 
the tetrameric forms were active, but showed different enzymatic properties. 
However, the hTK1 has also been reported to form tetramers regardless of the 
ATP incubation (Birringer, et al., 2006). Considering bacterial thymidine kinases, 
the Uu-TK and Ba-TK have been reported as dimers in solution (Carnrot, et al., 
2003; Carnrot, et al., 2006), but Ba-TK and Bc-TK have also been shown to form 
tetramers (Paper III). Nevertheless, all available crystal structures of TK1-like 
enzymes demonstrate similar tetrameric arrangement. The formation of the 
tetramer is independent of the space group and we can rule out that the tetramer is 
an artifact of crystallization. The oligomeric state of TK1-like enzymes might be a 
matter of concentration, but so far no unambiguous experiment has proven this to 
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be a correct assumption. From the structural point of view both the tetramer and 
the dimer should be able to exhibit enzymatic activity. The most probable dimer 
would in this case be the one formed by the β-sheet subunit-subunit interaction. 
This dimer would comprise two separate active sites with the bases of the 
phosphate donors partly exposed.   41 
4. Uridine-cytidine kinase 
Uridine-cytidine kinase (also called uridine kinase, uridine monophosphokinase, 
cytidine monophosphokinase; EC 2.7.1.48) catalyzes the phosphorylation of 
uridine or cytidine to their corresponding nucleoside monophosphates, UMP and 
CMP respectively. UCK exists in most cells and tissues, and  it has been observed 
that tumor cells generally express higher levels of UCK than normal cells 
(Herzfeld & Raper, 1979). Ehrlich ascites cells showed the highest activities of the 
enzyme, and therefore, most of the early work on UCK, was done with isolates 
from this particular type of tumor cells. 
 
UCK was proposed to be allosterically regulated, involving inhibition by CTP 
and UTP, and activation by ATP (Cheng, Payne & Traut, 1986). It was suggested 
that the feedback inhibitors, CTP and UTP, through binding to a regulatory site 
different from the active site, promoted dissociation of the active tetramer into 
inactive monomers. One of the substrates, ATP, was believed to reverse the effect 
of the feedback inhibitors, and to promote tetramer formation. Moreover, the 
transformation between the different polymeric states was proposed to be 
temperature dependent. However, new biochemical data (Ropp & Traut, 1998) 
and structural studies (Suzuki, et al., 2004) proved the hypothesis of allosteric 
activation wrong. Instead, it was shown that the feedback inhibitors act as 
bisubstrate analogs by occupying the phosphate acceptor site along with part of 
the phosphate donor site, and no dissociation of the tetramer upon inhibitor 
binding could be detected (Suzuki, et al., 2004). 
 
Cloning and expression of cDNA encoding UCK has facilitated the molecular 
characterization of the enzyme. Firstly, cDNA encoding UCK from mouse brain 
was cloned and expressed (Ropp & Traut, 1996), which was followed by cloning 
and expression of human UCK cDNA (Koizumi et al., 2001; Van Rompay, et al., 
2001). Two separate enzymes were identified and named UCK1 and UCK2 (Van 
Rompay, et al., 2001). UCK1 consists of 277 amino acids while UCK2 is 
somewhat shorter and contains 261 amino acids. This gives predicted molecular 
weights of 31 and 29 kDa for UCK1 and UCK2 subunits, respectively. The amino 
acid sequence identity between UCK1 and UCK2 is about 70%. 
 
Kinetic properties have been determined showing preferred phosphate acceptors 
and donors of the recombinant UCKs (Van Rompay, et al., 2001). Both enzymes 
are strict pyrimidine kinases, only phosphorylating uridine and cytidine, with 
higher Vmax with cytidine. Moreover, UCK1 exhibited 3- to 6-fold higher KM 
values for uridine and cytidine, and based on the kcat/KM values, was less efficient 
than UCK2. Both ATP and GTP act as efficient phosphate donors, and it has been 
reported that also deoxyribose triphosphates may act as phosphate donors. 
 
Interestingly, it was found that the expression of UCK1 and UCK2 is tissue 
dependent. High levels of UCK1 were detected in liver, kidney, skeletal muscle 
and heart and low amounts were found in brain, placenta, small intestine and 
spleen. On the other hand only low levels of UCK2 were measurable in placenta   42
(Van Rompay, et al., 2001). There are no clear explanations to this tissue specific 
expression but it is speculated to be coupled with regulatory processes.  
 
In addition to the natural substrates, UCK1 and UCK2 phosphorylate a number 
of nucleoside analogs, but with different phosphorylation efficiency (Van 
Rompay, et al., 2001). Recent studies reveal that UCK2, but not UCK1, is 
responsible for the phosphorylation of nucleoside analogs. Especially interesting 
for their antitumor activities are cyclopentenylcytosine (CPEC), which was 
undertaken for clinical trials in 2000 (Verschuur et al., 2000), and 3’-
ethynylcytidine (ECyd), which entered clinical trials in 2004 (Murata et al., 2004). 
In order to display their pharmacological effect, both these nucleoside analogs 
require activation through phosphorylation by UCK and subsequent kinase. ECyd-
triphosphate targets RNA Polymerase (Kang et al., 1989), while CPEC-
triphosphate has been shown to contribute to decreased CTP pools probably by 
acting as a CTP synthetase inhibitor (Tabata et al., 1997). Inhibition of RNA 
synthesis makes these analogs more efficient against slow growing solid tumors, 
where only a minor fraction of the cells is in the S phase and inhibition of the 
DNA synthesis is not possible.  
 
4.1 Structure determination of UCK1 (Paper IV) 
As part of the structure determination strategy practiced at Structural Genomics 
Consortium (SGC) a variety of UCK1 constructs were undertaken for 
crystallization trials. The constructs were designed based on domain boundary 
analysis using software created at SGC, and the UCK2 structure. Several 
constructs in the presence and absence of natural ligands (phosphate acceptors, 
phosphate donors, products and combinations thereof) gave rise to needle shaped 
crystals. These crystals belonged to the monoclinic space group C2 encompassing 
eight monomers in the asymmetric unit, giving rise to low quality diffraction data 
with the best resolution reaching 3 Å. 
 
The structure of UCK1 described here is based on a construct with N-terminal 
and C-terminal deletion of 21 and 35 amino acids, respectively. Particularly, the 
removal of the C-terminal residues facilitated better crystal packing, which 
resulted in hexagonal crystals belonging to the space group P6222, with one 
monomer in the asymmetric unit. The protein was crystallized in the presence of 
CMP. To some crystals the second product, ADP, was soaked in.  
 
The structure of UCK1 was solved by the molecular replacement method using 
one subunit of the product bound UCK2 as the search model. After several cycles 
of model building and refinement TLS refinement (Winn, Isupov & Murshudov, 
2001) with 5 groups was applied, which lowered the R and Rfree by approximately 
4% each. The TLS groups were obtained from the TLS Motion Determination 
server based on thermal motion of the model (Painter & Merritt, 2006). 
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4.2 The structure of UCK1 
4.2.1 Overall structure 
Human UCK1 is a member of the NMPK fold family, and is build up from four 
domains: the CORE, the NMP-binding domain and the LID domain (Fig. 12A). In 
addition to the classic NMPK domains, UCK1 has a fourth domain, which folds to 
a long β-hairpin and aligns with one edge of the β-sheet. The CORE domain is an 
α/β domain with a central, five stranded parallel β-sheet with two helices on each 
side. The CORE domain comprises the phosphate binding loop, or P-loop 
(G30GTASGKS37), which is situated in the junction between the first strand and 
the first helix of the enzyme. Two helical domains cover the CORE at the carboxy 
end of the central β-sheet. One of these domains is the NMP-binding domain, 
which includes one α-helix with surrounding loops. The second domain that 
covers the CORE is the LID domain consisting of two long helices joined by a 
loop making an antiparallel helix pair. Together, these domains make up the active 
site as described by Suzuki et al. (Suzuki, et al., 2004). The acceptor is recognized 
by the residues located in the NMP-binding domain, the β-hairpin and the LID 
domain. 
 
4.2.2 Quaternary structure 
Uridine cytidine kinase is a tetramer with 222 fold symmetry (Fig. 12B). There are 
two main types of subunit-subunit interaction. One is formed between helix G and 
strand 5 of the neighboring residues (Fig. 12C). The strands are aligned in an 
antiparallel way so that the two five-stranded β-sheets of bordering subunits form 
one ten-stranded β-sheet within the tetramer. The helices are not aligned to make 
an antiparallel helix-pair as is the case in thymidine kinases, rather they are tilted 
relative to each other and the subunit interaction is located at the C-termini of the 
helices. The second interaction is between the helices (helix E and helix F) in the 
LID domain. The interacting helices form a four helix bundle attached by 
hydrophobic and hydrophilic interactions (Fig. 12D). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. The structure of UCK1. A) The monomer of UCK1. B) The tetramer. C) The 
subunit- subunit interaction formed between strand 5 and helix G of each subunit. D) The 
four helix bundle subunit interaction.
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4.2.3 Ligand binding 
Although UCK1 was crystallized in presence of CMP there is only minor electron 
density corresponding to the ribose and phosphate moieties of the ligand. The 
density corresponding to the ligand is weaker in the crystals that were allowed to 
stay longer in the mother liquor before harvesting. Comparable observation was 
made by Appleby et al.  (Appleby et al., 2005) where they noticed decreased 
electron density for ADP in UCK2 crystals in complex with ADP and CMP that 
were kept a long time in mother liquor prior harvesting. In the ADP-soaked 
complex of UCK1, the CMP is fully absent. 
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ADP binds between the LID and the CORE domains at the strand-5-edge of the 
β-sheet. Compared to the phosphates, which are buried under the residues from 
helix E of the LID domain, the base and ribose are exposed. The ADP adenine 
ring makes stacking interactions with Arg168, and the exocyclic amino group 
(N6) of the adenine is hydrogen-bonded to the backbone carbonyl oxygen of 
Asp215. In UCK1 the adenine ring is bound in syn conformation, which is in 
contrast to how the adenine ring of ATP is bound in UCK2. The phosphates of the 
ADP form more interactions with the enzyme than the base and the ribose. 
Hydrogen bonds are formed between the phosphates and residues within the P-
loop. The interactions are mainly with main-chain atoms, but Lys36 and Ser37 
interact with their side chains. 
 
The internal flexibility of UCK1 is dependent on whether the enzyme is in 
ligand-free or ligand-bound state. High temperature factors of the residues situated 
in the acceptor binding domains are a result of a partly occupied substrate pocket. 
The work of Suzuki et al. (2004) shows that these regions become stabilized upon 
substrate binding. In addition to the β-hairpin, the NMP-binding domain and the 
LID domain, the B values are high for the residues situated on the loop between 
helix A and strand 2 and the loop connecting strand 5 with helix G. The last loop 
becomes less flexible when the phosphate donor binds to the enzyme. This is 
reflected by lower B factors for the residues in this region in the ADP complex 
compared with the ligand-free UCK1. 
 
4.3 Comparison with other enzymes 
4.3.1 Amino acid comparison 
The amino acid sequences of human UCK1 and UCK2 share 72% identity (Fig. 
13). As described earlier, uridine cytidine kinase is a very specific enzyme when it 
comes to the choice of the phosphate accepting substrate, and only uridine and 
cytidine are efficiently phosphorylated. On the basis of the structure of human 
UCK2 several residues were proposed to play a role as phosphate acceptor 
determinants (Suzuki, et al., 2004). A tyrosine, a histidine and an arginine 
(Tyr115, His120 and Arg178 using the human UCK1 numbering) bind the base of 
the acceptor. Depending on whether the base is a cytosine or a uracil, the tyrosine 
and the histidine swap between acting as hydrogen bond donor and acceptor. The 
pocket for the base is narrow and could not accommodate any purine bases. The 
preference for ribonucleoside over deoxyribonucleoside is assigned to an aspartic 
acid and an arginine (Asp87 and Arg169 in UCK1) which hydrogen bond with the 
2’-and 3’-hydroxyl groups of the ribose moiety. The catalytic base has been 
assigned to Asp65. These residues are conserved in UCK1 and UCK2. 
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P-loop
MAGDSEQTLQNHQQPNGGEPFLI GVSGGTASGKSSVC
MASAGGEDCESPAPEADRPHQR PFLI GVSGGTASGKSTVC
10 20 30 40
β1 αA
AKI VQLLGQNEVDYRQKQVVI LSQD SFYRVLTSEQKAKALKGQFNF
EKI MELLGQNEVEQRQRKVVI LSQD RFYKVLTAEQKAKALKGQYNF
50 60 70 80
β2 αB
DHPDAFDNELI LKTLKEI TEGKTVQI PVYDFVSHSRKEETVTVYPA
DHPDAFDNDLMHRTLKNI VEGKTVEVPTYDFVTHSRLPETTVVYPA
90 100 110 120 130
αC β1’ β2’ β3’ β4’
DVVLFEGI LAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDI SERG
DVVLFEGI LVFYSQEI RDMFHLRLFVDTDSDVRLSRRVLRDVR RG
140 150 160 170
β3 αD β4 αE
RDLEQI LSQYI TFVKPAFEEFCLPTKKYADVI I PRGADNLVAI NLI
RDLEQI LTQYTTFVKPAFEEFCLPTKKYADVI I PRGVDNMVAI NLI
180 190 200 210 220
αF β5
VQHI QDI LNGGPSKRQTNGCLNG YTPSRKRQA
VQHI QDI LNGDI CKW HRGGSNGRSYKRTFSEPGDHPGMLTSGKRSH
230 240 250 260
αG
SESSSRPH
LESSSRPH
270
❉
Fig. 13. Sequence alignment of human UCK1 (Q9HA47) and UCK2 (Q9BZX2). The second-
ary structure elements and the sequence numbering correspond to UCK1. Helix αB  corre-
sponds to the NMP-binding domain, the strands indicated with an apostrophe make up the 
β-hairpin motif, and helices αE and αF make up the LID domain. The P-loop motif is boxed, 
the catalytic base is indicated with a star, and the residues involved in acceptor binding are 
shown against gray background. The alignment was made using ClustalW (Chenna et al., 
2003) and Alscript (Barton 1993).  
 
4.3.2 Structural comparison 
4.3.2.1 UCK1 compared with UCK2 
The structures of human UCK1 and UCK2 are almost identical. This is not 
surprising when considering the high sequence identity between the two enzymes. 
It has been reported that UCK2 forms two types of tetramers in the crystals 
(Suzuki, et al., 2004). The ligand-free and the product-bound (ADP- and CMP-
bound) UCK2 form a symmetric tetramer with 222 fold symmetry. On the other 
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(Cyd-bound) UCK2 are distorted and less symmetrical. The biological relevance, 
if any, of the asymmetric tetramer is not known. UCK1 assembles into a 
symmetric tetramer similar to the one observed for the apo and product bound 
UCK2.  
 
Two main conformations of the UCK2 monomer have been described (Suzuki, 
et al., 2004). Depending on whether the phosphate acceptor site is occupied or 
empty the enzyme adopts a closed or an open conformation, respectively. The 
structure of UCK1 described in this thesis shows the enzyme in a semi-closed 
form (Fig. 14). The LID, the NMP-binding domain and the top of the β-hairpin are 
not as close to each other as in the UCK2 closed conformation, and they are not as 
separated as in the open conformation. Suzuki et al. proposed that the phosphate 
acceptor might bind in an ordered manner, where the ribose moiety binds first and 
induces formation of the base binding pocket. The semi-closed conformation of 
the UCK1 may be a representation of the sequential binding of the substrate such 
that the sugar moiety is bound but the base binding pocket is not yet formed, and 
therefore the cytosine and the ligating residues are flexible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CMP
ADP
UCK1 semi-closed
UCK2 open
UCK2 closed
Fig. 14. Superposition of semi-closed 
UCK1 (light gray) with  open UCK2 
(gray), and with closed UCK2 (black). The 
closed UCK2 is in complex with  ADP and 
CMP. The CORE domain was used for 
superposition.  
 
4.3.2.2 Comparison of a ribonucleoside kinase with a deoxyribonucleoside kinase 
Deoxyribonucleoside kinase (with exception of TK1-like enzymes) and 
ribonucleoside kinases are members of the NMPK fold family. Human dGK and 
UCK1 may be superimposed with an r.m.s.d. of 1.9 Å for 94 Cα atoms. The 
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and the NMP-binding domains of UCK are in dGK substituted by two helix-rich 
domains (Fig. 15). A further difference between the NKs and dNKs is the acceptor 
binding. UCK binds the base of the acceptor with residues situated on the β-
hairpin, the NMP-binding domain and the LID-domain, whereas in dGK the 
substrate is bound by residues situated on the helical domain, while the arginine 
rich LID domain binds the phosphates of the donor or feedback inhibitor 
(Johansson, et al., 2001). Unlike the tetrameric UCK, dGK is a dimer with the 
dimer interface formed between two long α-helices which correspond to the β-
hairpin in UCK. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UCK1 dGK
Fig. 15. Cartoon representation of  UCK1 and dGK monomers.  
 
What are the structural bases for UCK being a strict ribonucleoside kinase and 
dGK and TK for having a strong preference for deoxyribonucleosides? Both in 
dNKs and in TK1-like enzymes, the 3’-position is hydrogen-bonded to the 
enzyme. In dNKs there are two conserved amino acids, a tyrosine and a glutamic 
acid, that form hydrogen bonds between the side chains and the 3’-hydroxyl 
group. In the TK1-like enzymes the interaction is with the main chain atoms of a 
glycine situated on the lasso loop and a aspartic acid situated just at the beginning 
of the P-β-hairpin (Johansson, et al., 2001; Sabini, et al., 2003; Welin et al., 
2004). The 2’-position is in both enzyme families crowded with hydrophobic 
residues and a 2’-hydroxyl group would cause steric interference and hinder 
proper binding. In NKs however, there is an aspartic acid and an asparagine that 
form hydrogen bonds with 2’- and 3’-hydroxyl groups (Schumacher et al., 2000; 
Suzuki, et al., 2004). According to Suzuki et al. the binding tothe sugar moiety is 
crucial for the formation of the base recognition site (Suzuki, et al., 2004). 
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5. Conclusions and future perspectives 
5.1 Thymidine kinase 
The initial goal of this doctoral work was to determine the 3D-strucutre of TK 
from the opportunistic pathogen Ureaplasma urealyticum. U. urealyticum lacks 
the ability of de novo synthesis of dNTPs, and has to rely on its salvage enzymes, 
Uu-TK and dAK, for the synthesis of DNA precursors. Therefore, Uu-TK was 
evaluated as a potential prodrug activator for future antibacterial therapies. 
Moreover, to learn more about TKs, the structures of TKs of two bacillus species 
were determined. 
 
Based on the results described in this thesis we can divide dNKs into two 
structurally separate groups, where TK1-like enzymes create a group of their own. 
The only structural and sequential similarity between TK1-like enzymes and other 
dNKs is the P-loop situated on a junction between a β-strand and an α-helix. The 
active site of TK1-like enzymes is situated in a hydrophobic cleft between a rigid 
α/β domain and a flexible lasso domain. No major differences in the active sites of 
the bacterial TKs and hTK1 have been observed, which limits the future design of 
selective antibacterial agents. However, the structures described in this thesis 
provide interesting information regarding conformational changes during the time 
of reaction. The structures of the TKs where neither acceptor nor feedback 
inhibitor is bound show an open active site with a flexible lasso-domain. The lasso 
becomes stabilized upon substrate binding and closes down over the active site. A 
highly intriguing finding was the conformational change of the quaternary 
structure induced by the binding of dTTP at the phosphate donor site. A less tight 
tetramer is formed in the presence of a phosphate donor than when the donor site 
is unoccupied. 
 
A glutamic acid has been proposed to act as a catalytic base, but the complete 
picture of the reaction mechanism is still to be elucidated. For this purpose a 
productive complex is desirable. Complexes such as: TK with both substrates (a 
non-hydrolyzable ATP analog and dT) and Mg-ion, TK with both products (ADP 
and dTMP), bisubstrate analogs such as AP4dT or AP5dT with Mg-ion, and TK 
with Mg-ion, ADP, dT and suitable transition state mimicking compounds e.g. 
AlF4
¯, BeF3
¯. Moreover, the oligomeric structure of TK1-like enzymes needs 
further investigation. Hopefully, mutational studies, and native molecular mass 
determinations with ultracentrifugation and dynamic light scattering analysis, will 
clarify the matter of the oligomeric state of TKs. 
 
5.2 Uridine-cytidine kinase 1 
UCK1 is sequentially as well as structurally highly similar to UCK2. These 
enzymes have a tissue specific expression pattern and show different enzymatic 
properties. Structure determination of the UCK1 enzyme was conducted with the 
expectation to provide some possible explanations for those differences. In order 
to study the active site, the UCK1 was co-crystallized with CMP and soaked with   50
the second product ADP. While the structures of UCK2 show two major 
conformations of the enzyme (one open and one closed), the UCK1 was trapped in 
a semi-closed conformation. This form may support the hypothesis of a sequential 
substrate binding mode. The ADP binds in a similar way as to UCK2 with the 
exception for the adenine base which is in syn conformation in UCK1. There are 
not many interactions between the ring and the sugar of the ADP and the enzyme, 
which confirms the low specificity for the nucleotide as a phosphate donor. 
Unfortunately, the CMP did not bind strongly enough to stabilize the acceptor 
biding site. Many of the residues, which in UCK2 were identified as acceptor 
binding, are flexible in UCK1. More complex studies are therefore needed in order 
to explain the reasons for the diverse substrate specificities of UCK1 and UCK2.   51 
6. References 
Anand, K., Pal, D. & Hilgenfeld, R. 2002. An overview on 2-methyl-2,4-
pentanediol in crystallization and in crystals of biological macromolecules. Acta 
Crystallogr D Biol Crystallogr 58, 1722-8.  
Andersen, R.B. & Neuhard, J. 2001. Deoxynucleoside kinases encoded by the 
yaaG and yaaF genes of Bacillus subtilis. Substrate specificity and kinetic 
analysis of deoxyguanosine kinase with UTP as the preferred phosphate donor. J 
Biol Chem 276, 5518-24.  
Appleby, T.C., Larson, G., Cheney, I.W., Walker, H., Wu, J.Z., Zhong, W., Hong, 
Z. & Yao, N. 2005. Structure of human uridine-cytidine kinase 2 determined by 
SIRAS using a rotating-anode X-ray generator and a single samarium derivative. 
Acta Crystallogr D Biol Crystallogr 61, 278-84.  
Arnér, E.S. & Eriksson, S. 1995. Mammalian deoxyribonucleoside kinases. 
Pharmacol Ther 67, 155-86.  
Baillie, L. & Read, T.D. 2001. Bacillus anthracis, a bug with attitude! Curr Opin 
Microbiol 4, 78-81.  
Bauer, C.B., Fonseca, M.V., Holden, H.M., Thoden, J.B., Thompson, T.B., 
Escalante-Semerena, J.C. & Rayment, I. 2001. Three-dimensional structure of 
ATP:corrinoid adenosyltransferase from Salmonella typhimurium in its free 
state, complexed with MgATP, or complexed with hydroxycobalamin and 
MgATP. Biochemistry 40, 361-74.  
Barton, G.J. 1993. ALSCRIPT: a tool to format multiple sequence alignments. 
Protein Eng 6, 37-40. 
Bello, L.J. 1974. Regulation of thymidine kinase synthesis in human cells. Exp 
Cell Res 89, 263-74.  
Berenstein, D., Christensen, J.F., Kristensen, T., Hofbauer, R. & Munch-Petersen, 
B. 2000. Valine, not methionine, is amino acid 106 in human cytosolic 
thymidine kinase (TK1). Impact on oligomerization, stability, and kinetic 
properties. J Biol Chem 275, 32187-92.  
Bergfors, T. 2003. Seeds to crystals. J Struct Biol 142, 66-76.  
Berry, M.B. & Phillips, G.N., Jr. 1998. Crystal structures of Bacillus 
stearothermophilus adenylate kinase with bound Ap5A, Mg2+ Ap5A, and 
Mn2+ Ap5A reveal an intermediate lid position and six coordinate octahedral 
geometry for bound Mg2+ and Mn2+. Proteins 32, 276-88.  
Birringer, M.S., Claus, M.T., Folkers, G., Kloer, D.P., Schulz, G.E. & Scapozza, 
L. 2005. Structure of a type II thymidine kinase with bound dTTP. FEBS Lett 
579, 1376-82.  
Birringer, M.S., Perozzo, R., Kut, E., Stillhart, C., Surber, W., Scapozza, L. & 
Folkers, G. 2006. High-level expression and purification of human thymidine 
kinase 1: Quaternary structure, stability, and kinetics. Protein Expr Purif 47, 
506-15.  
Black, M.E. & Hruby, D.E. 1990a. Identification of the ATP-binding domain of 
vaccinia virus thymidine kinase. J Biol Chem 265, 17584-92.  
Black, M.E. & Hruby, D.E. 1990b. Quaternary structure of vaccinia virus 
thymidine kinase. Biochem Biophys Res Commun 169, 1080-6.    52
Black, M.E. & Hruby, D.E. 1992. Site-directed mutagenesis of a conserved 
domain in vaccinia virus thymidine kinase. Evidence for a potential role in 
magnesium binding. J Biol Chem 267, 6801-6.  
Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M. & Paciorek, W. 2003. 
Generation, representation and flow of phase information in structure 
determination: recent developments in and around SHARP 2.0. Acta Crystallogr 
D Biol Crystallogr 59, 2023-30.  
Briozzo, P., Evrin, C., Meyer, P., Assairi, L., Joly, N., Barzu, O. & Gilles, A.M. 
2005. Structure of Escherichia coli UMP kinase differs from that of other 
nucleoside monophosphate kinases and sheds new light on enzyme regulation. J 
Biol Chem 280, 25533-40.  
Brown, D.G., Visse, R., Sandhu, G., Davies, A., Rizkallah, P.J., Melitz, C., 
Summers, W.C. & Sanderson, M.R. 1995. Crystal structures of the thymidine 
kinase from herpes simplex virus type-1 in complex with deoxythymidine and 
ganciclovir. Nat Struct Biol 2, 876-81.  
Carnrot, C., Wehelie, R., Eriksson, S., Bolske, G. & Wang, L. 2003. Molecular 
characterization of thymidine kinase from Ureaplasma urealyticum: nucleoside 
analogues as potent inhibitors of mycoplasma growth. Mol Microbiol 50, 771-
80.  
Carnrot, C., Vogel, S.R., Byun, Y., Wang, L., Tjarks, W., Eriksson, S. & Phipps, 
A.J. 2006. Evaluation of Bacillus anthracis thymidine kinase as a potential 
target for the development of antibacterial nucleoside analogs. Biol Chem 387, 
1575-81.  
Chabes, A. & Thelander, L. 2000. Controlled protein degradation regulates 
ribonucleotide reductase activity in proliferating mammalian cells during the 
normal cell cycle and in response to DNA damage and replication blocks. J Biol 
Chem 275, 17747-53.  
Chabes, A.L., Pfleger, C.M., Kirschner, M.W. & Thelander, L. 2003. Mouse 
ribonucleotide reductase R2 protein: a new target for anaphase-promoting 
complex-Cdh1-mediated proteolysis. Proc Natl Acad Sci U S A 100, 3925-9.  
Champness, J.N., Bennett, M.S., Wien, F., Visse, R., Summers, W.C., Herdewijn, 
P., de Clerq, E., Ostrowski, T., Jarvest, R.L. & Sanderson, M.R. 1998. Exploring 
the active site of herpes simplex virus type-1 thymidine kinase by X-ray 
crystallography of complexes with aciclovir and other ligands. Proteins 32, 350-
61.  
Chen, M.S., Summers, W.P., Walker, J., Summers, W.C. & Prusoff, W.H. 1979. 
Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) 
and thymidylate kinase as a multifunctional enzyme in cells transformed by 
herpes simplex virus type 1 and in cells infected with mutant strains of herpes 
simplex virus. J Virol 30, 942-5.  
Chen, M.S., Walker, J. & Prusoff, W.H. 1979. Kinetic studies of herpes simplex 
virus type 1-encoded thymidine and thymidylate kinase, a multifunctional 
enzyme. J Biol Chem 254, 10747-53.  
Cheng, N., Payne, R.C. & Traut, T.W. 1986. Regulation of uridine kinase. 
Evidence for a regulatory site. J Biol Chem 261, 13006-12.  
Barton, G.J. 1993. ALSCRIPT: a tool to format multiple sequence alignments. 
Protein Eng 6, 37-40.    53 
Chenna, R., Sugawara, Hideaki, Koike,Tadashi, Lopez, Rodrigo, Gibson, Toby J, 
Higgins, Desmond G, Thompson, Julie D 2003. Multiple sequence alignment 
with the Clustal series of programs. Nucleic Acids Res 31, 3497-500 
Cho, Y., Gorina, S., Jeffrey, P.D. & Pavletich, N.P. 1994. Crystal structure of a 
p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. 
Science 265, 346-55.  
Coppock, D.L. & Pardee, A.B. 1987. Control of thymidine kinase mRNA during 
the cell cycle. Mol Cell Biol 7, 2925-32.  
De Clercq, E. 2001. Antiviral drugs: current state of the art. J Clin Virol 22, 73-89.  
de La Fortelle, E. & Irwin, J. 1997. SHARP: A Maximum-Likelihood Heavy-
Atom Parameter Refinement Program for the MIR and MAD Methods. Methods 
Enzymol 276, 472-494.  
Dixon, T.C., Meselson, M., Guillemin, J. & Hanna, P.C. 1999. Anthrax. N Engl J 
Med 341, 815-26.  
Ducruix, A. & Giegé, R. 1992. Crysrallization of Nucleic Acids and Proteins: A 
Practicle Approach. Oxford Univ. Press, London.  pp. 
El Omari, K., Solaroli, N., Karlsson, A., Balzarini, J. & Stammers, D.K. 2006. 
Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for 
drug design. BMC Struct Biol 6, 22.  
Eriksson, S., Kierdaszuk, B., Munch-Petersen, B., Öberg, B. & Johansson, N.G. 
1991. Comparison of the substrate specificities of human thymidine kinase 1 and 
2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. 
Biochem Biophys Res Commun 176, 586-92.  
Eriksson, S., Munch-Petersen, B., Johansson, K. & Eklund, H. 2002. Structure and 
function of cellular deoxyribonucleoside kinases. Cell Mol Life Sci 59, 1327-46.  
Galmarini, C.M., Mackey, J.R. & Dumontet, C. 2002. Nucleoside analogues and 
nucleobases in cancer treatment. Lancet Oncol 3, 415-24.  
Gentry, G.A. 1992. Viral thymidine kinases and their relatives. Pharmacol Ther 
54, 319-55.  
Gilles, A.M., Glaser, P., Perrier, V., Meier, A., Longin, R., Sebald, M., Maignan, 
L., Pistotnik, E. & Barzu, O. 1994. Zinc, a structural component of adenylate 
kinases from gram-positive bacteria. J Bacteriol 176, 520-3.  
Gilles, A.M., Presecan, E., Vonica, A. & Lascu, I. 1991. Nucleoside diphosphate 
kinase from human erythrocytes. Structural characterization of the two 
polypeptide chains responsible for heterogeneity of the hexameric enzyme. J 
Biol Chem 266, 8784-9.  
Glass, J.I., Lefkowitz, E.J., Glass, J.S., Heiner, C.R., Chen, E.Y. & Cassell, G.H. 
2000. The complete sequence of the mucosal pathogen Ureaplasma urealyticum. 
Nature 407, 757-62.  
Gronowitz, J.S., Kallander, F.R., Diderholm, H., Hagberg, H. & Pettersson, U. 
1984. Application of an in vitro assay for serum thymidine kinase: results on 
viral disease and malignancies in humans. Int J Cancer 33, 5-12.  
Guittet, O., Håkansson, P., Voevodskaya, N., Fridd, S., Graslund, A., Arakawa, 
H., Nakamura, Y. & Thelander, L. 2001. Mammalian p53R2 protein forms an 
active ribonucleotide reductase in vitro with the R1 protein, which is expressed 
both in resting cells in response to DNA damage and in proliferating cells. J Biol 
Chem 276, 40647-51.  
Härd, T., Kellenbach, E., Boelens, R., Maler, B.A., Dahlman, K., Freedman, L.P., 
Carlstedt-Duke, J., Yamamoto, K.R., Gustafsson, J.Å. & Kaptein, R. 1990.   54
Solution structure of the glucocorticoid receptor DNA-binding domain. Science 
249, 157-60.  
Harlow, K.W., Nygaard, P. & Hove-Jensen, B. 1995. Cloning and characterization 
of the gsk gene encoding guanosine kinase of Escherichia coli. J Bacteriol 177, 
2236-40.  
He, Q., Zhang, P., Zou, L., Li, H., Wang, X., Zhou, S., Fornander, T. & Skog, S. 
2005. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive 
proliferation marker in human solid tumors than its activity. Oncol Rep 14, 
1013-9.  
He, Q., Zou, L., Zhang, P.A., Lui, J.X., Skog, S. & Fornander, T. 2000. The 
clinical significance of thymidine kinase 1 measurement in serum of breast 
cancer patients using anti-TK1 antibody. Int J Biol Markers 15, 139-46.  
Heidelberger, C., Chaudhuri, N.K., Danneberg, P., Mooren, D., Griesbach, L., 
Duschinsky, R., Schnitzer, R.J., Pleven, E. & Scheiner, J. 1957. Fluorinated 
pyrimidines, a new class of tumour-inhibitory compounds. Nature 179, 663-6.  
Herzfeld, A. & Raper, S.M. 1979. Uridine kinase activities in developing, adult 
and neoplastic rat tissues. Biochem J 182, 771-8.  
Holm, L. & Sander, C. 1993. Protein structure comparison by alignment of 
distance matrices. J Mol Biol 233, 123-38.  
Hruby, D.E. & Ball, L.A. 1982. Mapping and identification of the vaccinia virus 
thymidine kinase gene. J Virol 43, 403-9.  
Huang, S.H., Tang, A., Drisco, B., Zhang, S.Q., Seeger, R., Li, C. & Jong, A. 
1994. Human dTMP kinase: gene expression and enzymatic activity coinciding 
with cell cycle progression and cell growth. DNA Cell Biol 13, 461-71.  
Ichikawa, W. 2006. Prediction of clinical outcome of fluoropyrimidine-based 
chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil 
metabolic pathway. Gastric Cancer 9, 145-55.  
Ives, D.H. & Ikeda, S. 1998. Life on the salvage path: the deoxynucleoside kinase 
of Lactobacillus acidophilus R-26. Prog Nucleic Acid Res Mol Biol 59, 205-55.  
Ives, D.H., Morse, P.A., Jr. & Potter, V.R. 1963. Feedback inhibition of thymidine 
kinase by thymidine triphosphate. J Biol Chem 238, 1467-74.  
Janin, J., Dumas, C., Morera, S., Xu, Y., Meyer, P., Chiadmi, M. & Cherfils, J. 
2000. Three-dimensional structure of nucleoside diphosphate kinase. J Bioenerg 
Biomembr 32, 215-25.  
Jensen, G.B., Hansen, B.M., Eilenberg, J. & Mahillon, J. 2003. The hidden 
lifestyles of Bacillus cereus and relatives. Environ Microbiol 5, 631-40.  
Johansson, K., Ramaswamy, S., Ljungcrantz, C., Knecht, W., Piskur, J., Munch-
Petersen, B., Eriksson, S. & Eklund, H. 2001. Structural basis for substrate 
specificities of cellular deoxyribonucleoside kinases. Nat Struct Biol 8, 616-20.  
Kang, G.J., Cooney, D.A., Moyer, J.D., Kelley, J.A., Kim, H.Y., Marquez, V.E. & 
Johns, D.G. 1989. Cyclopentenylcytosine triphosphate. Formation and inhibition 
of CTP synthetase. J Biol Chem 264, 713-8.  
Karlström, H.O. 1970. Inability of Escherichia coli B to incorporate added 
deoxycytidine, deoxyandenosine, and deoxyguanosine into DNA. Eur J 
Biochem 17, 68-71.  
Katahira, R. & Ashihara, H. 2006. Profiles of purine biosynthesis, salvage and 
degradation in disks of potato (Solanum tuberosum L.) tubers. Planta 225, 115-
26.    55 
Kauffman, M.G. & Kelly, T.J. 1991. Cell cycle regulation of thymidine kinase: 
residues near the carboxyl terminus are essential for the specific degradation of 
the enzyme at mitosis. Mol Cell Biol 11, 2538-46.  
Ke, P.Y. & Chang, Z.F. 2004. Mitotic degradation of human thymidine kinase 1 is 
dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated 
pathway. Mol Cell Biol 24, 514-26.  
Kimura, N., Shimada, N., Fukuda, M., Ishijima, Y., Miyazaki, H., Ishii, A., 
Takagi, Y. & Ishikawa, N. 2000. Regulation of cellular functions by nucleoside 
diphosphate kinases in mammals. J Bioenerg Biomembr 32, 309-15.  
Knecht, W., Petersen, G.E., Munch-Petersen, B. & Piskur, J. 2002a. 
Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like 
group vary significantly in substrate specificity, kinetics and feed-back 
regulation. J Mol Biol 315, 529-40.  
Knecht, W., Petersen, G.E., Sandrini, M.P., Søndergaard, L., Munch-Petersen, B. 
& Piskur, J. 2003. Mosquito has a single multisubstrate deoxyribonucleoside 
kinase characterized by unique substrate specificity. Nucleic Acids Res 31, 1665-
72.  
Knecht, W., Sandrini, M.P., Johansson, K., Eklund, H., Munch-Petersen, B. & 
Piskur, J. 2002b. A few amino acid substitutions can convert 
deoxyribonucleoside kinase specificity from pyrimidines to purines. Embo J 21, 
1873-80.  
Koizumi, K., Shimamoto, Y., Azuma, A., Wataya, Y., Matsuda, A., Sasaki, T. & 
Fukushima, M. 2001. Cloning and expression of uridine/cytidine kinase cDNA 
from human fibrosarcoma cells. Int J Mol Med 8, 273-8.  
Kotiranta, A., Lounatmaa, K. & Haapasalo, M. 2000. Epidemiology and 
pathogenesis of Bacillus cereus infections. Microbes Infect 2, 189-98.  
Kuzin, A.P., Abashidze, M., Forouhar, F., Vorobiev, S. M., Acton, T. B., Ma, L.-
C., Xiao, R., Montelione, G. T., Tong, L., Hunt, J. F. 2004. X-Ray Structure of 
Clostridium Acetobutylicum Thymidine Kinase with ADP. Northeast Structural 
Genomics Target Car26. PDB code: 1XX6 
Lacombe, M.L., Milon, L., Munier, A., Mehus, J.G. & Lambeth, D.O. 2000. The 
human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32, 247-
58.  
Li, H.X., Lei, D.S., Wang, X.Q., Skog, S. & He, Q. 2005. Serum thymidine kinase 
1 is a prognostic and monitoring factor in patients with non-small cell lung 
cancer. Oncol Rep 13, 145-9.  
Liu, Q.Y. & Summers, W.C. 1988. Site-directed mutagenesis of a nucleotide-
binding domain in HSV-1 thymidine kinase: effects on catalytic activity. 
Virology 163, 638-42.  
Mikkelsen, N.E., Johansson, K., Karlsson, A., Knecht, W., Andersen, G., Piskur, 
J., Munch-Petersen, B. & Eklund, H. 2003. Structural basis for feedback 
inhibition of the deoxyribonucleoside salvage pathway: studies of the 
Drosophila deoxyribonucleoside kinase. Biochemistry 42, 5706-12.  
Miller, W.H. & Miller, R.L. 1991. Guanosine kinase from Trichomonas vaginalis. 
Mol Biochem Parasitol 48, 39-46.  
Møllgaard, H. 1980. Deoxyadenosine/deoxycytidine kinase from Bacillus subtilis. 
Purification, characterization, and physiological function. J Biol Chem 255, 
8216-20.    56
Munch-Petersen, B., Cloos, L., Tyrsted, G. & Eriksson, S. 1991. Diverging 
substrate specificity of pure human thymidine kinases 1 and 2 against antiviral 
dideoxynucleosides. J Biol Chem 266, 9032-8.  
Munch-Petersen, B., Piskur, J. & Søndergaard, L. 1998. Four deoxynucleoside 
kinase activities from Drosophila melanogaster are contained within a single 
monomeric enzyme, a new multifunctional deoxynucleoside kinase. J Biol Chem 
273, 3926-31.  
Munch-Petersen, B., Tyrsted, G. & Cloos, L. 1993. Reversible ATP-dependent 
transition between two forms of human cytosolic thymidine kinase with different 
enzymatic properties. J Biol Chem 268, 15621-5.  
Murata, D., Endo, Y., Obata, T., Sakamoto, K., Syouji, Y., Kadohira, M., 
Matsuda, A. & Sasaki, T. 2004. A crucial role of uridine/cytidine kinase 2 in 
antitumor activity of 3'-ethynyl nucleosides. Drug Metab Dispos 32, 1178-82.  
Niculescu-Duvaz, I. & Springer, C.J. 2005. Introduction to the background, 
principles, and state of the art in suicide gene therapy. Mol Biotechnol 30, 71-88.  
Nordlund, P. & Reichard, P. 2006. Ribonucleotide reductases. Annu Rev Biochem 
75, 681-706.  
Okinaka, R., Cloud, K., Hampton, O., Hoffmaster, A., Hill, K., Keim, P., Koehler, 
T., Lamke, G., Kumano, S., Manter, D., Martinez, Y., Ricke, D., Svensson, R. & 
Jackson, P. 1999. Sequence, assembly and analysis of pX01 and pX02. J Appl 
Microbiol 87, 261-2.  
Painter, J. & Merritt, E.A. 2006. Optimal description of a protein structure in 
terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol 
Crystallogr 62, 439-50.  
Plagemann, P.G., Wohlhueter, R.M. & Woffendin, C. 1988. Nucleoside and 
nucleobase transport in animal cells. Biochim Biophys Acta 947, 405-43.  
Pollack, J.D., Myers, M.A., Dandekar, T. & Herrmann, R. 2002. Suspected utility 
of enzymes with multiple activities in the small genome Mycoplasma species: 
the replacement of the missing "household" nucleoside diphosphate kinase gene 
and activity by glycolytic kinases. Omics 6, 247-58.  
Rasko, D.A., Altherr, M.R., Han, C.S. & Ravel, J. 2005. Genomics of the Bacillus 
cereus group of organisms. FEMS Microbiol Rev 29, 303-29.  
Reichard, P. 1988. Interactions between deoxyribonucleotide and DNA synthesis. 
Annu Rev Biochem 57, 349-74.  
Reinstein, J., Brune, M. & Wittinghofer, A. 1988. Mutations in the nucleotide 
binding loop of adenylate kinase of Escherichia coli. Biochemistry 27, 4712-20.  
Reinstein, J., Schlichting, I. & Wittinghofer, A. 1990. Structurally and 
catalytically important residues in the phosphate binding loop of adenylate 
kinase of Escherichia coli. Biochemistry 29, 7451-9.  
Robertson, J.A., Stemke, G.W., Davis, J.W., Jr., Harasawa, R., Thirkell, D., Kong, 
F., Shepard, M.C. & Ford, D.K. 2002. Proposal of Ureaplasma parvum sp. nov. 
and emended description of Ureaplasma urealyticum (Shepard et al. 1974) 
Robertson et al. 2001. Int J Syst Evol Microbiol 52, 587-97.  
Ropp, P.A. & Traut, T.W. 1996. Cloning and expression of a cDNA encoding 
uridine kinase from mouse brain. Arch Biochem Biophys 336, 105-12.  
Ropp, P.A. & Traut, T.W. 1998. Uridine kinase: altered enzyme with decreased 
affinities for uridine and CTP. Arch Biochem Biophys 359, 63-8.    57 
Sabini, E., Ort, S., Monnerjahn, C., Konrad, M. & Lavie, A. 2003. Structure of 
human dCK suggests strategies to improve anticancer and antiviral therapy. Nat 
Struct Biol 10, 513-9.  
Saito, H. & Tomioka, H. 1984. Thymidine kinase of bacteria: activity of the 
enzyme in actinomycetes and related organisms. J Gen Microbiol 130, 1863-70.  
Saito, H., Tomioka, H. & Ohkido, S. 1985. Further studies on thymidine kinase: 
distribution pattern of the enzyme in bacteria. J Gen Microbiol 131, 3091-8.  
Sandrini, M.P., Clausen, A.R., Munch-Petersen, B. & Piskur, J. 2006. Thymidine 
kinase diversity in bacteria. Nucleosides Nucleotides Nucleic Acids 25, 1153-8.  
Saraste, M., Sibbald, P.R. & Wittinghofer, A. 1990. The P-loop--a common motif 
in ATP- and GTP-binding proteins. Trends Biochem Sci 15, 430-4.  
Schneider, T.R. & Sheldrick, G.M. 2002. Substructure solution with SHELXD. 
Acta Crystallogr D Biol Crystallogr 58, 1772-9.  
Schumacher, M.A., Scott, D.M., Mathews, II, Ealick, S.E., Roos, D.S., Ullman, B. 
& Brennan, R.G. 2000. Crystal structures of Toxoplasma gondii adenosine 
kinase reveal a novel catalytic mechanism and prodrug binding. J Mol Biol 298, 
875-93.  
Sherley, J.L. & Kelly, T.J. 1988a. Human cytosolic thymidine kinase. Purification 
and physical characterization of the enzyme from HeLa cells. J Biol Chem 263, 
375-82.  
Sherley, J.L. & Kelly, T.J. 1988b. Regulation of human thymidine kinase during 
the cell cycle. J Biol Chem 263, 8350-8.  
Sigal, I.S., Gibbs, J.B., D'Alonzo, J.S., Temeles, G.L., Wolanski, B.S., Socher, 
S.H. & Scolnick, E.M. 1986. Mutant ras-encoded proteins with altered 
nucleotide binding exert dominant biological effects. Proc Natl Acad Sci U S A 
83, 952-6.  
Singh, B., Hao, W., Wu, Z., Eigl, B. & Gupta, R.S. 1996. Cloning and 
characterization of cDNA for adenosine kinase from mammalian (Chinese 
hamster, mouse, human and rat) species. High frequency mutants of Chinese 
hamster ovary cells involve structural alterations in the gene. Eur J Biochem 
241, 564-71.  
Smith, D.G., Russell, W.C., Ingledew, W.J. & Thirkell, D. 1993. Hydrolysis of 
urea by Ureaplasma urealyticum generates a transmembrane potential with 
resultant ATP synthesis. J Bacteriol 175, 3253-8.  
Spychala, J., Datta, N.S., Takabayashi, K., Datta, M., Fox, I.H., Gribbin, T. & 
Mitchell, B.S. 1996. Cloning of human adenosine kinase cDNA: sequence 
similarity to microbial ribokinases and fructokinases. Proc Natl Acad Sci U S A 
93, 1232-7.  
Story, R.M., Weber, I.T. & Steitz, T.A. 1992. The structure of the E. coli recA 
protein monomer and polymer. Nature 355, 318-25.  
Stura, E. & Wilson, I. 1990. Analytical and Production Seeding Techniques. 
Methods 1, 38-49.  
Suzuki, N.N., Koizumi, K., Fukushima, M., Matsuda, A. & Inagaki, F. 2004. 
Structural basis for the specificity, catalysis, and regulation of human uridine-
cytidine kinase. Structure 12, 751-64.  
Tabata, S., Tanaka, M., Endo, Y., Obata, T., Matsuda, A. & Sasaki, T. 1997. Anti-
tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis 
inhibitors: development and characterization of 3'-ethynyluridine-resistant cells. 
Cancer Lett 116, 225-31.    58
Tian, G.C., Yan, H.G., Jiang, R.T., Kishi, F., Nakazawa, A. & Tsai, M.D. 1990. 
Mechanism of adenylate kinase. Are the essential lysines essential? 
Biochemistry 29, 4296-304.  
Traut, T.W. 1994. Physiological concentrations of purines and pyrimidines. Mol 
Cell Biochem 140, 1-22.  
Waites, K.B., Katz, B. & Schelonka, R.L. 2005. Mycoplasmas and ureaplasmas as 
neonatal pathogens. Clin Microbiol Rev 18, 757-89.  
Van Rompay, A.R., Johansson, M. & Karlsson, A. 2000. Phosphorylation of 
nucleosides and nucleoside analogs by mammalian nucleoside monophosphate 
kinases. Pharmacol Ther 87, 189-98.  
Van Rompay, A.R., Norda, A., Linden, K., Johansson, M. & Karlsson, A. 2001. 
Phosphorylation of uridine and cytidine nucleoside analogs by two human 
uridine-cytidine kinases. Mol Pharmacol 59, 1181-6.  
Wang, L., Westberg, J., Bolske, G. & Eriksson, S. 2001. Novel deoxynucleoside-
phosphorylating enzymes in mycoplasmas: evidence for efficient utilization of 
deoxynucleosides. Mol Microbiol 42, 1065-73.  
Welin, M., Kosinska, U., Mikkelsen, N.E., Carnrot, C., Zhu, C., Wang, L., 
Eriksson, S., Munch-Petersen, B. & Eklund, H. 2004. Structures of thymidine 
kinase 1 of human and mycoplasmic origin. Proc Natl Acad Sci U S A 101, 
17970-5.  
Verschuur, A.C., Van Gennip, A.H., Leen, R., Muller, E.J., Elzinga, L., Voute, 
P.A. & Van Kuilenburg, A.B. 2000. Cyclopentenyl cytosine inhibits cytidine 
triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a 
promising target for chemotherapy. Eur J Cancer 36, 627-35.  
Wild, K., Bohner, T., Aubry, A., Folkers, G. & Schulz, G.E. 1995. The three-
dimensional structure of thymidine kinase from herpes simplex virus type 1. 
FEBS Lett 368, 289-92.  
Wild, K., Bohner, T., Folkers, G. & Schulz, G.E. 1997. The structures of 
thymidine kinase from herpes simplex virus type 1 in complex with substrates 
and a substrate analogue. Protein Sci 6, 2097-106.  
Winn, M.D., Isupov, M.N. & Murshudov, G.N. 2001. Use of TLS parameters to 
model anisotropic displacements in macromolecular refinement. Acta 
Crystallogr D Biol Crystallogr 57, 122-33.  
Xu, Y.W., Morera, S., Janin, J. & Cherfils, J. 1997. AlF3 mimics the transition 
state of protein phosphorylation in the crystal structure of nucleoside 
diphosphate kinase and MgADP. Proc Natl Acad Sci U S A 94, 3579-83.  
Yan, H. & Tsai, M.D. 1999. Nucleoside monophosphate kinases: structure, 
mechanism, and substrate specificity. Adv Enzymol Relat Areas Mol Biol 73, 
103-34, x.  
Zhang, J., Jia, Q., Zou, S., Zhang, P., Zhang, X., Skog, S., Luo, P., Zhang, W. & 
He, Q. 2006. Thymidine kinase 1: a proliferation marker for determining 
prognosis and monitoring the surgical outcome of primary bladder carcinoma 
patients. Oncol Rep 15, 455-61.  
Zou, L., Zhang, P.G., Zou, S., Li, Y. & He, Q. 2002. The half-life of thymidine 
kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring 
the response to surgery of patients with gastric cancer. Int J Biol Markers 17, 
135-40.    59 
Acknowledgements 
First and foremost I would like to thank my supervisors. Hasse, thank you for 
your optimism, patience and good discussions Thank you for letting me work so 
independently. Even if work sometimes felt frustrating and impossible, it was also 
very satisfying and I now feel prepared for the next step. Thank you Fredrik for 
your encouragement and for taking the car to the lab in the middle of a Friday 
night to turn of the cryo-generator. 
 
I would also like to thank TK-collaborators: Staffan Eriksson and his crew (Liya, 
Rahma, Cicci, Elena, Ashraf) for interesting kinase-meetings, journal club and 
teaching us some enzyme kinetics. Special thanks goes to Cicci, for your never 
ending supply of fresh protein whenever I needed more, and for our small chats 
about mostly everything. It was enjoyable to collaborate with you. The “crazy” 
professor Jure Piskur and Michael Sandrini for taking good care of Martin and 
me when we visited your lab. Jure, Michael and Anders, thank you for good 
collaboration on the Bc-TK project. 
 
My gratitude goes also to SGC at Karolinska Institutet for giving me the 
opportunity to work with you. Thank you all the members of the consortium for 
creating a nice working atmosphere. In particular I would like to thank the 
members of Team 1, Pär Nordlund, Pål Stenmark, Tomas Nyman, Susanne 
Flodin, Martin Moche, for sharing your projects with me. 
 
I would like to thank Ulf Willen from Malvern Instruments, Uppsala, for your 
kind help with the DLS experiments on Ba-TK and Bc-TK. 
 
Thank you: Vladimir, my first room-mate, for your short questions. Andrea my 
second room-mate for giving great concerts, being a master of Illustrator, and for 
sharing knäckebröd and your fascination for ncRNA. Professor and Hinas is a 
perfect combination. Good luck in Boston. We’ll come and visit you. Thank you 
Martin for sharing the struggle with TKs, running the BK Modestos and for 
making Lousie come back to us. Nisse for being so enthusiastic about the latest 
releases of Linux and for being keen on trying them all out on my computer. 
Lotta, thank you for your positive thinking and lied-back stile in combination with 
enthusiasm for what you are doing. Keep on fishing! Glareh, thank you for your 
contiguous laughter. Anton and Anatoly for asking questions at the group 
meetings. Jessica for being an excellent master student. Malin and Rosie, you are 
simply the best! Thanks for the support, chats, laughs, synchrotron and skiing 
trips. Malin, you did a fantastic performance on P3, explaining crystallography to 
the late-night listeners. Thank you Rosie, for e-mailing me before I had even 
started in the group. Thank you Jenny and Gösta for your company in Florence, 
and all the fun in Piza, at Monte Carla and Blobban. The Poles for teaching me 
some “lab-Polish”. Agata for always caring about other people. I’m glad you 
decided to return to Uppsala. Thank you Wojtek for our discussions and 
remember that some projects might be worth working on even with expressions 
below 7 mg/L culture.   60
 
Thank you Stefan for taking good care of the department, Ulla,  Jerry and 
Margareta for fine leadership with the biochemistry courses, and Elleonor for 
your help with all administrative related issues. The place would not work without 
the great efforts and technical support from Erling and Christer. Thank you 
Christer for lending your hair-drier (twice).  
 
There would be no structures without synchrotron trips. Many thanks to Inger and 
Karin for leading our BAG. Thank you Karin, Linda, Al and Sara for great 
company during the late nights at the beamlines. 
 
Alwyn, I am thankful for your help with O, especially during model building of 
the first Uu-TK structure. 
 
Thank you Tex for a great crystallization course and for always having a piece of 
advice when it comes to purification and crystallization problems. 
 
Thank you: Anna J., Anna L., Adrian, Mark, Patrik, Emma, Talal (I miss your 
fantastic dinners), Andreas K., Sherry, Gerard, Marian, EvaLena, all the boys 
in the Åqvist group, all boys and girls working with Janos and David, Magnus, 
Pavel (I hope my lead-prophecy wont come true), Annette, Nisse, Maria, Mats, 
Jonas,  Sanju,  Martin  S.,  Lars,  Kaspars,  Wimal,  Seved,  Torsten,  Tom, 
Christofer, Nina, Alina, Daniel, Henrik x2 , Ulrika, Lena, Dee, Monika,...for 
making BMC a great place to work at. 
 
I would also like to thank a few people outside the lab. My oldest friends Agata 
and Dorota for always being there, even though you are so far away.. Jenny and 
Sofia for all the fun we’ve had together. My “Karlstad-friends”: Peder, Anna, 
världens bästa Karlsson, Goswin (det ordnade sig, precis som du alltid säger), 
Daniel, Jocke, Johan, Rickard, Johanna P., B., Mikael and the girls, my dearest 
friends Sara, Anna and Cilla (never stop asking questions) for our fabulous study 
sessions. 
 
Thank you Johan and Lisa for all the fun here in Uppsala. Skål för Kamutasha! 
 
Maćku to dzięki tobie znalazłam się w Uppsali, więc i ty się nie co przyczyniłes 
do tej pracy. Zawsze miałeś coś wesołego do opowiedzenia gdy tu studiowałes a 
ja, tak już od małego, chciałam być tam gdzie starszy brat bo tam zawsze 
najfajniej. Ponieważ jestem dość pamiętliwa chcę ci przypomnieć  że wciąż 
czekam na te Birkenstocki które mi obiecałas jakieś pięć lat temu ☺. 
 
Kochanej mamie i kochanemu ojcu za nieustające wsparcie. Bez was nie dałabym 
sobie rady. Dziekuję wam za wszystko. 
 
Slutligen vill jag tacka Jonas för att du flyttade till Uppsala. Ditt stöd har betytt 
väldigt mycket för mig inte minst under den senaste tiden. Tack för de fina 
överraskningarna. 
 